Human Gene VEGFA (uc003owh.3) Description and Page Index
  Description: Homo sapiens vascular endothelial growth factor A (VEGFA), transcript variant 1, mRNA.
RefSeq Summary (NM_001171623): This gene is a member of the PDGF/VEGF growth factor family. It encodes a heparin-binding protein, which exists as a disulfide-linked homodimer. This growth factor induces proliferation and migration of vascular endothelial cells, and is essential for both physiological and pathological angiogenesis. Disruption of this gene in mice resulted in abnormal embryonic blood vessel formation. This gene is upregulated in many known tumors and its expression is correlated with tumor stage and progression. Elevated levels of this protein are found in patients with POEMS syndrome, also known as Crow-Fukase syndrome. Allelic variants of this gene have been associated with microvascular complications of diabetes 1 (MVCD1) and atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been described. There is also evidence for alternative translation initiation from upstream non-AUG (CUG) codons resulting in additional isoforms. A recent study showed that a C-terminally extended isoform is produced by use of an alternative in-frame translation termination codon via a stop codon readthrough mechanism, and that this isoform is antiangiogenic. Expression of some isoforms derived from the AUG start codon is regulated by a small upstream open reading frame, which is located within an internal ribosome entry site. [provided by RefSeq, Nov 2015].
Transcript (Including UTRs)
   Position: hg19 chr6:43,737,946-43,754,223 Size: 16,278 Total Exon Count: 8 Strand: +
Coding Region
   Position: hg19 chr6:43,738,444-43,752,299 Size: 13,856 Coding Exon Count: 8 

Page IndexSequence and LinksUniProtKB CommentsGenetic AssociationsMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated: 2013-06-15

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr6:43,737,946-43,754,223)mRNA (may differ from genome)Protein (232 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
BioGPSCGAPEnsemblEntrez GeneExonPrimerGeneCards
H-INVHGNCHPRDLynxMGIneXtProt
OMIMPubMedReactomeStanford SOURCETreefamUniProtKB
Wikipedia

-  Comments and Description Text from UniProtKB
  ID: VEGFA_HUMAN
DESCRIPTION: RecName: Full=Vascular endothelial growth factor A; Short=VEGF-A; AltName: Full=Vascular permeability factor; Short=VPF; Flags: Precursor;
FUNCTION: Growth factor active in angiogenesis, vasculogenesis and endothelial cell growth. Induces endothelial cell proliferation, promotes cell migration, inhibits apoptosis and induces permeabilization of blood vessels. Binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth.
SUBUNIT: Homodimer; disulfide-linked. Also found as heterodimer with PGF (By similarity).
INTERACTION: P17948:FLT1; NbExp=2; IntAct=EBI-1026643, EBI-1026718;
SUBCELLULAR LOCATION: Secreted. Note=VEGF121 is acidic and freely secreted. VEGF165 is more basic, has heparin-binding properties and, although a signicant proportion remains cell-associated, most is freely secreted. VEGF189 is very basic, it is cell-associated after secretion and is bound avidly by heparin and the extracellular matrix, although it may be released as a soluble form by heparin, heparinase or plasmin.
TISSUE SPECIFICITY: Isoform VEGF189, isoform VEGF165 and isoform VEGF121 are widely expressed. Isoform VEGF206 and isoform VEGF145 are not widely expressed.
INDUCTION: Regulated by growth factors, cytokines, gonadotropins, nitric oxide, hypoxia, hypoglycemia and oncogenic mutations.
DISEASE: Defects in VEGFA are a cause of susceptibility to microvascular complications of diabetes type 1 (MVCD1) [MIM:603933]. These are pathological conditions that develop in numerous tissues and organs as a consequence of diabetes mellitus. They include diabetic retinopathy, diabetic nephropathy leading to end-stage renal disease, and diabetic neuropathy. Diabetic retinopathy remains the major cause of new-onset blindness among diabetic adults. It is characterized by vascular permeability and increased tissue ischemia and angiogenesis.
SIMILARITY: Belongs to the PDGF/VEGF growth factor family.
SEQUENCE CAUTION: Sequence=AAC63102.1; Type=Erroneous initiation; Sequence=AAC63143.1; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon; Sequence=CAC19512.2; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon; Sequence=CAC19516.2; Type=Miscellaneous discrepancy; Note=Unusual initiator. The initiator methionine is coded by a non-canonical CTG leucine codon;
WEB RESOURCE: Name=R&D Systems' cytokine mini-reviews: VEGF; URL="http://www.rndsystems.com/molecule_detail.aspx?m=2247";
WEB RESOURCE: Name=Wikipedia; Note=VEGF entry; URL="http://en.wikipedia.org/wiki/Vascular_endothelial_growth_factor";
WEB RESOURCE: Name=SeattleSNPs; URL="http://pga.gs.washington.edu/data/vegf/";

-  Genetic Association Studies of Complex Diseases and Disorders
  Genetic Association Database (archive): VEGFA
CDC HuGE Published Literature: VEGFA
Positive Disease Associations: 18F-fluorodeoxyglucose uptake , acute renal allograft rejection , Adiponectin , ALS/amyotrophic lateral sclerosis , Alzheimer's disease , Alzheimer's disease; vascular endothelial growth factor levels , atherosclerosis, coronary , benzene haematotoxicity , bladder cancer , breast cancer , Carcinoma, Squamous Cell|Mouth Neoplasms|Neovascularization, Pathologic , Colitis, Ulcerative , colorectal cancer , coronary artery bypass , Coronary Artery Disease , cutaneous malignant melanoma , Diabetes Mellitus, Type 2 , diabetes, type 1 diabetic nephropathy , diabetes, type 1; nephropathy in other diseases , diabetes, type 2 , diabetes, type 2 retinopathy, diabetic , diabetic nephropathy; retinopathy, diabetic , Diabetic Retinopathy in Type 2 Diabetes , endometriosis , Endometriosis| , Erythrocyte Count , Femur Head Necrosis| , giant cell arteritis , heart anomalies, congenital , heart failure , Heart Failure|Myocardial Infarction , Heart Septal Defects, Ventricular|Ventricular Septal Defects , heart transplant complications , hemodialysis , Henoch-Schonlein purpura; nephritis, Henoch-Schonlein , kawasaki disease , kidney cancer , Kidney Diseases , Leiomyoma|Uterine Neoplasms , longevity , lung cancer , macular degeneration , monocyte chemoattractant protein 1 (66-77) , myocardial infarct , nephropathy, IgA , oral cancer , ovarian cancer , Pre-Eclampsia , pregnancy loss, recurrent , preterm delivery , prostate cancer , psoriasis , Pterygium , renal disease, end stage vascular endothelial growth factor , respiratory distress syndrome , retinopathy , retinopathy of prematurity , retinopathy, diabetic , retinopathy, diabetic; macular edema , rheumatoid arthritis , sarcoidosis , SIDS/sudden infant death syndrome , spontaneous preterm delivery. , stomach cancer , stomach cancer vascular endothelial growth factor levels , Stomach Neoplasms , type 2 diabetes , urinary calculus , vascular endothelial growth factor , Vascular Endothelial Growth Factor A , Waist-Hip Ratio
Related Studies:
  1. 18F-fluorodeoxyglucose uptake
    Wolf, G. et al. 2004, The 936CT polymorphism of the gene for vascular endothelial growth factor is associated with 18F-fluorodeoxyglucose uptake, Breast cancer research and treatment. 2004 Dec;88(3):205-8. [PubMed 15609122]
    In the present study the common VEGF 936CT polymorphisms had a major impact on 18F-FDG uptake in breast cancer patients. If this result can be confirmed in following studies, it might have strong relevance for the use of PET as diagnostic tool.
  2. acute renal allograft rejection
    Shahbazi M et al. 2002, Vascular endothelial growth factor gene polymorphisms are associated with acute renal allograft rejection., Journal of the American Society of Nephrology. 2002 Jan;13(1):260-4. [PubMed 11752046]
  3. Adiponectin
    Zari Dastani et al. PLoS genetics 2012, Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals., PLoS genetics. [PubMed 22479202]
           more ... click here to view the complete list

-  MalaCards Disease Associations
  MalaCards Gene Search: VEGFA
Diseases sorted by gene-association score: microvascular complications of diabetes 1* (623), microvascular complications of diabetes 1, susceptibility* (100), poems syndrome (45), diabetic macular edema (36), corneal neovascularization (35), retinal vein occlusion (35), central retinal vein occlusion (32), neovascular glaucoma (32), ischemia (31), retinal vascular disease (27), macular retinal edema (27), chronic myocardial ischemia (26), limb ischemia (25), kaposi sarcoma (21), microvascular complications of diabetes 5 (21), ovarian hyperstimulation syndrome (20), kuhnt-junius degeneration (19), kidney cancer (18), critical limb ischemia (18), juvenile nasopharyngeal angiofibroma (18), hemangioma (18), mucinous adenocarcinoma of the appendix (18), pulmonary aspergilloma (18), oral cavity cancer (17), globe disease (16), pancreatic cancer (16), rubeosis iridis (15), vascular cancer (14), malignant glioma (14), endometriosis (13), retinal ischemia (13), acute mountain sickness (13), diabetic neuropathy (13), renal clear cell carcinoma (13), osteonecrosis of the jaw (13), adamantinous craniopharyngioma (13), lung cancer (13), hepatocellular carcinoma (12), colorectal cancer (12), leukostasis (12), von hippel-lindau syndrome (12), coats disease (11), background diabetic retinopathy (11), degenerative myopia (11), vascular disease (11), angiodysplasia (11), renal cell carcinoma (11), arteriovenous malformation (11), retinal detachment (11), osteonecrosis (11), peripheral artery disease (10), hypoglycemic coma (10), retinal vascular occlusion (10), severe nonproliferative diabetic retinopathy (10), dupuytren contracture (10), atherosclerosis (10), ovarian cyst (10), wrinkles (10), placental insufficiency (10), breast carcinoma in situ (10), stomach cancer (10), severe pre-eclampsia (10), macular dystrophy, patterned, 3 (10), pediatric angiosarcoma (9), degeneration of macula and posterior pole (9), ovarian cancer, somatic (9), serous cystadenocarcinoma (9), endometrial adenocarcinoma (9), primary effusion lymphoma (9), astrocytoma (9), glioblastoma (9), pituitary tumors (9), adenomyosis (9), fallopian tube carcinoma (9), diabetic polyneuropathy (9), vascular dementia (8), pericardial effusion (8), epithelioid hemangioendothelioma (8), posterior uveal melanoma (8), preretinal fibrosis (8), pyogenic granuloma (8), intravascular papillary endothelial hyperplasia (8), hemifacial spasm (8), chronic mountain sickness (8), macular dystrophy, dominant cystoid (8), oral squamous cell carcinoma (8), hereditary hemorrhagic telangiectasia (8), ectopic pregnancy (8), pre-eclampsia (8), lymphangioma (8), vitreous disease (8), patterned macular dystrophy (8), hypertensive nephropathy (8), brain edema (8), left ventricular outflow tract obstruction (7), rosacea (7), eye disease (7), intermittent claudication (7), ocular melanoma (7), exudative vitreoretinopathy 1 (7), sick building syndrome (7), acute endophthalmitis (7), moyamoya disease (7), cystadenocarcinoma (7), angiomatous meningioma (7), pancreatic ductal carcinoma (7), squamous cell carcinoma, head and neck (7), skin hemangioma (7), angioid streaks (7), endometrial cancer (7), peripheral vascular disease (7), hydrops, lactic acidosis, and sideroblastic anemia (7), gastric lymphoma (7), neuroretinitis (7), hepatopulmonary syndrome (7), shwachman-diamond syndrome (7), pancreatic serous cystadenoma (7), large cell carcinoma with rhabdoid phenotype (7), mucinous stomach adenocarcinoma (7), endophthalmitis (7), soft tissue sarcoma (7), median neuropathy (7), intracranial hemorrhage in brain cerebrovascular malformations (7), peritoneal mesothelioma (7), hemangioblastoma (7), macular degeneration, age-related, 1 (6), capillary hemangioma (6), clear cell renal cell carcinoma (6), odontogenic myxoma (6), wallerian degeneration (6), mucositis (6), hypoxia (6), malignant ovarian surface epithelial-stromal neoplasm (6), ovary epithelial cancer (6), glomeruloid hemangioma (6), yemenite deaf-blind hypopigmentation syndrome (6), portal hypertension (6), angiosarcoma (6), grade iii astrocytoma (6), tuberculous meningitis (6), adenocarcinoma (6), spindle cell sarcoma (6), cancer-associated retinopathy (6), breast cancer (6), diabetic cataract (6), idiopathic interstitial pneumonia (6), renal pelvis carcinoma (6), eales disease (6), melanoma metastasis (6), macular holes (5), eye degenerative disease (5), angiokeratoma circumscriptum (5), ovarian serous cystadenocarcinoma (5), t-cell prolymphocytic leukemia (5), lung cancer susceptibility 3 (5), infiltrating angiolipoma (5), radiation proctitis (5), peripartum cardiomyopathy (5), ischemic bone disease (5), lipodermatosclerosis (5), hydrocele (5), microcystic meningioma (5), colon adenoma (5), gastrointestinal neuroendocrine tumor (5), cardiovascular cancer (5), cell type cancer (5), rheumatoid arthritis (5), preeclampsia/eclampsia 1 (5), primary peritoneal carcinoma (5), opiate dependence (5), carcinoid syndrome (5), gastrointestinal system cancer (5), purulent endophthalmitis (5), female reproductive organ cancer (5), glioblastoma multiforme (5), reproductive organ cancer (5), telangiectasis (4), pleural cancer (4), lymphangiosarcoma (4), lens disease (4), acute hemorrhagic leukoencephalitis (4), peliosis hepatis (4), epileptic encephalopathy, childhood-onset (4), retinal hemangioblastoma (3), geographic tongue (3), esophageal cancer (3), pancreatic ductal adenocarcinoma (3), hematologic cancer (3), sleep apnea (3), differentiated thyroid carcinoma (3), urinary bladder cancer (3), colorectal adenocarcinoma (3), prostate cancer (3), multiple myeloma (2), gastrointestinal stromal tumor (2), artery disease (2), uveal melanoma (2), tetralogy of fallot (2), adamantinoma of long bones (2), brain cancer (2), motor neuron disease (2), pulmonary hypertension (2), bladder cancer, somatic (2), malaria (2), myocardial infarction (2), female reproductive system disease (1), nervous system disease (1), corneal disease (1), gastric cancer, somatic (1), connective tissue cancer (1), male reproductive organ cancer (1)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 251.92 RPKM in Thyroid
Total median expression: 1935.73 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -199.70498-0.401 Picture PostScript Text
3' UTR -597.391924-0.310 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR000072 - PD_growth_factor
IPR023581 - PD_growth_factor_CS

Pfam Domains:
PF00341 - PDGF/VEGF domain
PF14554 - VEGF heparin-binding domain

SCOP Domains:
57501 - Cystine-knot cytokines
57593 - Heparin-binding domain from vascular endothelial growth factor

Protein Data Bank (PDB) 3-D Structure
MuPIT help

1BJ1
- X-ray MuPIT

1CZ8
- X-ray MuPIT

1FLT
- X-ray MuPIT
To conserve bandwidth, only the images from the first 3 structures are shown.
1KAT - NMR MuPIT 1KMX - NMR MuPIT 1MJV - X-ray MuPIT
1MKG - X-ray MuPIT 1MKK - X-ray MuPIT 1QTY - X-ray MuPIT
1TZH - X-ray MuPIT 1TZI - X-ray MuPIT 1VGH - NMR MuPIT
1VPF - X-ray MuPIT 1VPP - X-ray MuPIT 2FJG - X-ray MuPIT
2FJH - X-ray MuPIT 2QR0 - X-ray 2VGH - NMR MuPIT
2VPF - X-ray MuPIT 3BDY - X-ray MuPIT 3P9W - X-ray MuPIT
3QTK - X-ray 3S1B - X-ray MuPIT 3S1K - X-ray MuPIT
3V2A - X-ray MuPIT 4DEQ - X-ray MuPIT 4GLN - X-ray
4GLS - X-ray


ModBase Predicted Comparative 3D Structure on P15692
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologGenome BrowserNo orthologNo orthologNo orthologNo ortholog
 Gene Details    
 Gene Sorter    
 RGD    
 Protein Sequence    
 Alignment    

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0001968 fibronectin binding
GO:0005125 cytokine activity
GO:0005161 platelet-derived growth factor receptor binding
GO:0005172 vascular endothelial growth factor receptor binding
GO:0005515 protein binding
GO:0008083 growth factor activity
GO:0008201 heparin binding
GO:0038191 neuropilin binding
GO:0042056 chemoattractant activity
GO:0042802 identical protein binding
GO:0042803 protein homodimerization activity
GO:0043183 vascular endothelial growth factor receptor 1 binding
GO:0043184 vascular endothelial growth factor receptor 2 binding
GO:0046982 protein heterodimerization activity
GO:0048018 receptor agonist activity
GO:0050840 extracellular matrix binding

Biological Process:
GO:0000122 negative regulation of transcription from RNA polymerase II promoter
GO:0001525 angiogenesis
GO:0001541 ovarian follicle development
GO:0001569 branching involved in blood vessel morphogenesis
GO:0001570 vasculogenesis
GO:0001666 response to hypoxia
GO:0001701 in utero embryonic development
GO:0001822 kidney development
GO:0001934 positive regulation of protein phosphorylation
GO:0001938 positive regulation of endothelial cell proliferation
GO:0002042 cell migration involved in sprouting angiogenesis
GO:0002052 positive regulation of neuroblast proliferation
GO:0002053 positive regulation of mesenchymal cell proliferation
GO:0002092 positive regulation of receptor internalization
GO:0002575 basophil chemotaxis
GO:0002576 platelet degranulation
GO:0002687 positive regulation of leukocyte migration
GO:0003007 heart morphogenesis
GO:0003151 outflow tract morphogenesis
GO:0003169 coronary vein morphogenesis
GO:0006357 regulation of transcription from RNA polymerase II promoter
GO:0007275 multicellular organism development
GO:0007399 nervous system development
GO:0007498 mesoderm development
GO:0007595 lactation
GO:0008284 positive regulation of cell proliferation
GO:0008360 regulation of cell shape
GO:0010469 regulation of receptor activity
GO:0010595 positive regulation of endothelial cell migration
GO:0010628 positive regulation of gene expression
GO:0010629 negative regulation of gene expression
GO:0019221 cytokine-mediated signaling pathway
GO:0030154 cell differentiation
GO:0030224 monocyte differentiation
GO:0030225 macrophage differentiation
GO:0030324 lung development
GO:0030335 positive regulation of cell migration
GO:0030823 regulation of cGMP metabolic process
GO:0030855 epithelial cell differentiation
GO:0030949 positive regulation of vascular endothelial growth factor receptor signaling pathway
GO:0031077 post-embryonic camera-type eye development
GO:0031334 positive regulation of protein complex assembly
GO:0031954 positive regulation of protein autophosphorylation
GO:0032147 activation of protein kinase activity
GO:0032793 positive regulation of CREB transcription factor activity
GO:0033138 positive regulation of peptidyl-serine phosphorylation
GO:0035148 tube formation
GO:0035767 endothelial cell chemotaxis
GO:0035924 cellular response to vascular endothelial growth factor stimulus
GO:0036303 lymph vessel morphogenesis
GO:0038033 positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway
GO:0038084 vascular endothelial growth factor signaling pathway
GO:0038091 positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway
GO:0038190 VEGF-activated neuropilin signaling pathway
GO:0040007 growth
GO:0042327 positive regulation of phosphorylation
GO:0042462 eye photoreceptor cell development
GO:0043066 negative regulation of apoptotic process
GO:0043117 positive regulation of vascular permeability
GO:0043129 surfactant homeostasis
GO:0043154 negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
GO:0043406 positive regulation of MAP kinase activity
GO:0043536 positive regulation of blood vessel endothelial cell migration
GO:0045766 positive regulation of angiogenesis
GO:0045785 positive regulation of cell adhesion
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0048010 vascular endothelial growth factor receptor signaling pathway
GO:0048469 cell maturation
GO:0048593 camera-type eye morphogenesis
GO:0048739 cardiac muscle fiber development
GO:0048754 branching morphogenesis of an epithelial tube
GO:0048842 positive regulation of axon extension involved in axon guidance
GO:0048844 artery morphogenesis
GO:0050679 positive regulation of epithelial cell proliferation
GO:0050731 positive regulation of peptidyl-tyrosine phosphorylation
GO:0050918 positive chemotaxis
GO:0050927 positive regulation of positive chemotaxis
GO:0050930 induction of positive chemotaxis
GO:0051272 positive regulation of cellular component movement
GO:0051781 positive regulation of cell division
GO:0051894 positive regulation of focal adhesion assembly
GO:0060319 primitive erythrocyte differentiation
GO:0060749 mammary gland alveolus development
GO:0060754 positive regulation of mast cell chemotaxis
GO:0060948 cardiac vascular smooth muscle cell development
GO:0060982 coronary artery morphogenesis
GO:0061418 regulation of transcription from RNA polymerase II promoter in response to hypoxia
GO:0061419 positive regulation of transcription from RNA polymerase II promoter in response to hypoxia
GO:0070374 positive regulation of ERK1 and ERK2 cascade
GO:0071456 cellular response to hypoxia
GO:0071542 dopaminergic neuron differentiation
GO:0071679 commissural neuron axon guidance
GO:0090037 positive regulation of protein kinase C signaling
GO:0090050 positive regulation of cell migration involved in sprouting angiogenesis
GO:0090190 positive regulation of branching involved in ureteric bud morphogenesis
GO:0090259 regulation of retinal ganglion cell axon guidance
GO:0097475 motor neuron migration
GO:0097533 cellular stress response to acid chemical
GO:1900086 positive regulation of peptidyl-tyrosine autophosphorylation
GO:1900745 positive regulation of p38MAPK cascade
GO:1901727 positive regulation of histone deacetylase activity
GO:1902336 positive regulation of retinal ganglion cell axon guidance
GO:1902966 positive regulation of protein localization to early endosome
GO:1903572 positive regulation of protein kinase D signaling
GO:1903589 positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis
GO:1903672 positive regulation of sprouting angiogenesis
GO:0042531 positive regulation of tyrosine phosphorylation of STAT protein

Cellular Component:
GO:0005576 extracellular region
GO:0005615 extracellular space
GO:0005737 cytoplasm
GO:0009986 cell surface
GO:0016020 membrane
GO:0030141 secretory granule
GO:0031012 extracellular matrix
GO:0031093 platelet alpha granule lumen


-  Descriptions from all associated GenBank mRNAs
  LQ270778 - Sequence 106 from Patent WO2016071350.
DM163655 - Method for promotion of p53 expression.
E15157 - Human VEGF mRNA.
DM163611 - Method for promotion of p53 expression.
LQ270776 - Sequence 104 from Patent WO2016071350.
LQ270780 - Sequence 108 from Patent WO2016071350.
LQ270782 - Sequence 110 from Patent WO2016071350.
LQ270784 - Sequence 112 from Patent WO2016071350.
LQ270786 - Sequence 114 from Patent WO2016071350.
LQ270788 - Sequence 116 from Patent WO2016071350.
LQ270790 - Sequence 118 from Patent WO2016071350.
LQ270792 - Sequence 120 from Patent WO2016071350.
LQ270794 - Sequence 122 from Patent WO2016071350.
LQ270796 - Sequence 124 from Patent WO2016071350.
LQ270798 - Sequence 126 from Patent WO2016071350.
LQ270800 - Sequence 128 from Patent WO2016071350.
LQ270802 - Sequence 130 from Patent WO2016071350.
LQ270804 - Sequence 132 from Patent WO2016071350.
LQ270806 - Sequence 134 from Patent WO2016071350.
LQ270808 - Sequence 136 from Patent WO2016071350.
LQ270812 - Sequence 140 from Patent WO2016071350.
BC058855 - Homo sapiens cDNA clone IMAGE:5313912, containing frame-shift errors.
FW406912 - NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF.
FW406913 - NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF.
FW406914 - NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF.
FW406915 - NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF.
FW406916 - NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF.
FW406917 - NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF.
FW406918 - NUCLEIC ACID COMPOUNDS FOR INHIBITING VEGF FAMILY GENE EXPRESSION AND USES THEREOF.
JA810025 - Sequence 1158 from Patent EP2468864.
JA810026 - Sequence 1159 from Patent EP2468864.
JA810027 - Sequence 1160 from Patent EP2468864.
JA810028 - Sequence 1161 from Patent EP2468864.
JA810029 - Sequence 1162 from Patent EP2468864.
JA810030 - Sequence 1163 from Patent EP2468864.
JA810031 - Sequence 1164 from Patent EP2468864.
BC019867 - Homo sapiens cDNA clone IMAGE:4153053.
JD527734 - Sequence 508758 from Patent EP1572962.
JD483976 - Sequence 465000 from Patent EP1572962.
JD078358 - Sequence 59382 from Patent EP1572962.
JD067239 - Sequence 48263 from Patent EP1572962.
AF022375 - Homo sapiens vascular endothelial growth factor mRNA, complete cds.
JD442060 - Sequence 423084 from Patent EP1572962.
JD440682 - Sequence 421706 from Patent EP1572962.
JD409055 - Sequence 390079 from Patent EP1572962.
JD482550 - Sequence 463574 from Patent EP1572962.
BC172307 - Synthetic construct Homo sapiens clone IMAGE:100069001, MGC:199012 vascular endothelial growth factor A (VEGFA) mRNA, encodes complete protein.
BC011177 - Homo sapiens vascular endothelial growth factor A, mRNA (cDNA clone IMAGE:4150451), partial cds.
BC065522 - Homo sapiens vascular endothelial growth factor A, mRNA (cDNA clone IMAGE:6006890), partial cds.
HW917787 - JP 2015062388-A/12: Method for detecting G-quadruplex of nucleic acid strand.
DM163640 - Method for promotion of p53 expression.
DM163642 - Method for promotion of p53 expression.
JD480960 - Sequence 461984 from Patent EP1572962.
JD471504 - Sequence 452528 from Patent EP1572962.
JD473028 - Sequence 454052 from Patent EP1572962.
JD485364 - Sequence 466388 from Patent EP1572962.
JD480969 - Sequence 461993 from Patent EP1572962.
JD468390 - Sequence 449414 from Patent EP1572962.
DD104476 - METHODS FOR IDENTIFYING SMALL MOLECULES THAT BIND SPECIFIC RNA STRUCTURAL MOTIFS.
DL193403 - Methods and Agents for Screening for Compounds Capable of Modulating Gene Expression.
HV349896 - JP 2011103886-A/19: Methods and Agents for Screening for Compounds Capable of Modulating Gene Expression.
HV959545 - JP 2012187106-A/19: Methods and Agents for Screening for Compounds Capable of Modulating Gene Expression.
HW805014 - JP 2015015950-A/19: Methods and Agents for Screening for Compounds Capable of Modulating Gene Expression.
JB318390 - Sequence 19 from Patent EP2351859.
JB767748 - Sequence 19 from Patent EP2500437.
M27281 - Human vascular permeability factor mRNA, complete cds.
JD459120 - Sequence 440144 from Patent EP1572962.
JD339614 - Sequence 320638 from Patent EP1572962.
JD476104 - Sequence 457128 from Patent EP1572962.
JD405660 - Sequence 386684 from Patent EP1572962.
JD443502 - Sequence 424526 from Patent EP1572962.
S85192 - Homo sapiens vascular endothelial growth factor mRNA, partial cds.
M32977 - Human heparin-binding vascular endothelial growth factor (VEGF) mRNA, complete cds.
E15156 - Human VEGF mRNA.
AY047581 - Homo sapiens vascular endothelial growth factor (VEGF) mRNA, complete cds.
X62568 - H.sapiens vegf gene for vascular endothelial growth factor.
GQ129408 - Synthetic construct Homo sapiens clone HAIB:100068504; DKFZo004E1034 vascular endothelial growth factor A protein (VEGFA) gene, partial cds.
EU832814 - Synthetic construct Homo sapiens clone HAIB:100067843; DKFZo008E1033 vascular endothelial growth factor A protein (VEGFA) gene, encodes complete protein.
CU688060 - Synthetic construct Homo sapiens gateway clone IMAGE:100021527 5' read VEGFA mRNA.
KJ892374 - Synthetic construct Homo sapiens clone ccsbBroadEn_01768 VEGFA gene, encodes complete protein.
FW553366 - IRNA AGENTS TARGETING VEGF.
HI963072 - Sequence 2 from Patent EP1735009.
HV496311 - JP 2011518117-A/1539: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496955 - JP 2011518117-A/2183: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982694 - JP 2011188866-A/2: IRNA AGENTS TARGETING VEGF.
HZ401828 - JP 2015177801-A/1539: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402472 - JP 2015177801-A/2183: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419925 - JP 2014094020-A/2: IRNA AGENTS TARGETING VEGF.
LZ247096 - JP 2016135144-A/2: IRNA AGENTS TARGETING VEGF.
AY263145 - Homo sapiens MDA-MB 231 vascular endothelial growth factor A splice variant VEGF 117 (VEGF) mRNA, complete cds; alternatively spliced.
AB451451 - Homo sapiens VEGFA mRNA for vascular endothelial growth factor isoform VEGF165, partial cds, clone: FLJ08203AAAF.
AY766116 - Homo sapiens vascular endothelial growth factor mRNA, partial cds.
AB451322 - Homo sapiens VEGFA mRNA for vascular endothelial growth factor isoform VEGF165, complete cds, clone: FLJ08203AAAN.
AB021221 - Homo sapiens mRNA for vascular endothelial growth factor isoform VEGF165, complete cds.
AF091352 - Homo sapiens vascular permeability factor 148 mRNA, complete cds.
AF214570 - Homo sapiens vascular endothelial growth factor isoform 121 precursor, mRNA, complete cds.
AF486837 - Homo sapiens vascular endothelial growth factor isoform VEGF165 (VEGF) mRNA, complete cds.
AJ010438 - Homo sapiens mRNA for vascular endothelial growth factor, splicing variant VEGF183.
AY500353 - Homo sapiens vascular endothelial growth factor-like (VEGF) mRNA, complete sequence.
DQ229900 - Homo sapiens vascular endothelial cell growth factor A isoform (VEGF) mRNA, complete cds, alternatively spliced.
FW553365 - IRNA AGENTS TARGETING VEGF.
HH927486 - Sequence 1539 from Patent WO2010105209.
HI963071 - Sequence 1 from Patent EP1735009.
HV496310 - JP 2011518117-A/1538: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV967733 - JP 2012520082-A/1538: LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982693 - JP 2011188866-A/1: IRNA AGENTS TARGETING VEGF.
HZ401827 - JP 2015177801-A/1538: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419924 - JP 2014094020-A/1: IRNA AGENTS TARGETING VEGF.
KT581011 - Homo sapiens vascular endothelial growth factor A165 mRNA, partial cds.
LZ247095 - JP 2016135144-A/1: IRNA AGENTS TARGETING VEGF.
LZ250641 - JP 2016168053-A/1538: LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
AF430806 - Homo sapiens vascular endothelial growth factor 165b mRNA, complete cds, alternatively spliced.
FW553367 - IRNA AGENTS TARGETING VEGF.
HI963073 - Sequence 3 from Patent EP1735009.
HV496312 - JP 2011518117-A/1540: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982695 - JP 2011188866-A/3: IRNA AGENTS TARGETING VEGF.
HZ401829 - JP 2015177801-A/1540: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419926 - JP 2014094020-A/3: IRNA AGENTS TARGETING VEGF.
LZ247097 - JP 2016135144-A/3: IRNA AGENTS TARGETING VEGF.
FW553368 - IRNA AGENTS TARGETING VEGF.
HI963074 - Sequence 4 from Patent EP1735009.
HV496313 - JP 2011518117-A/1541: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982696 - JP 2011188866-A/4: IRNA AGENTS TARGETING VEGF.
HZ401830 - JP 2015177801-A/1541: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419927 - JP 2014094020-A/4: IRNA AGENTS TARGETING VEGF.
LZ247098 - JP 2016135144-A/4: IRNA AGENTS TARGETING VEGF.
FW553369 - IRNA AGENTS TARGETING VEGF.
HI963075 - Sequence 5 from Patent EP1735009.
HV496314 - JP 2011518117-A/1542: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982697 - JP 2011188866-A/5: IRNA AGENTS TARGETING VEGF.
HZ401831 - JP 2015177801-A/1542: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419928 - JP 2014094020-A/5: IRNA AGENTS TARGETING VEGF.
LZ247099 - JP 2016135144-A/5: IRNA AGENTS TARGETING VEGF.
FW553370 - IRNA AGENTS TARGETING VEGF.
HI963076 - Sequence 6 from Patent EP1735009.
HV496315 - JP 2011518117-A/1543: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982698 - JP 2011188866-A/6: IRNA AGENTS TARGETING VEGF.
HZ401832 - JP 2015177801-A/1543: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419929 - JP 2014094020-A/6: IRNA AGENTS TARGETING VEGF.
LZ247100 - JP 2016135144-A/6: IRNA AGENTS TARGETING VEGF.
FW553371 - IRNA AGENTS TARGETING VEGF.
HI963077 - Sequence 7 from Patent EP1735009.
HV496316 - JP 2011518117-A/1544: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982699 - JP 2011188866-A/7: IRNA AGENTS TARGETING VEGF.
HZ401833 - JP 2015177801-A/1544: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419930 - JP 2014094020-A/7: IRNA AGENTS TARGETING VEGF.
LZ247101 - JP 2016135144-A/7: IRNA AGENTS TARGETING VEGF.
FW553372 - IRNA AGENTS TARGETING VEGF.
HI963078 - Sequence 8 from Patent EP1735009.
HV496317 - JP 2011518117-A/1545: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982700 - JP 2011188866-A/8: IRNA AGENTS TARGETING VEGF.
HZ401834 - JP 2015177801-A/1545: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419931 - JP 2014094020-A/8: IRNA AGENTS TARGETING VEGF.
LZ247102 - JP 2016135144-A/8: IRNA AGENTS TARGETING VEGF.
FW553373 - IRNA AGENTS TARGETING VEGF.
HI963079 - Sequence 9 from Patent EP1735009.
HV496318 - JP 2011518117-A/1546: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982701 - JP 2011188866-A/9: IRNA AGENTS TARGETING VEGF.
HZ401835 - JP 2015177801-A/1546: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419932 - JP 2014094020-A/9: IRNA AGENTS TARGETING VEGF.
LZ247103 - JP 2016135144-A/9: IRNA AGENTS TARGETING VEGF.
FW553374 - IRNA AGENTS TARGETING VEGF.
HI963080 - Sequence 10 from Patent EP1735009.
HV496319 - JP 2011518117-A/1547: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982702 - JP 2011188866-A/10: IRNA AGENTS TARGETING VEGF.
HZ401836 - JP 2015177801-A/1547: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419933 - JP 2014094020-A/10: IRNA AGENTS TARGETING VEGF.
LZ247104 - JP 2016135144-A/10: IRNA AGENTS TARGETING VEGF.
FW553375 - IRNA AGENTS TARGETING VEGF.
HI963081 - Sequence 11 from Patent EP1735009.
HV496320 - JP 2011518117-A/1548: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982703 - JP 2011188866-A/11: IRNA AGENTS TARGETING VEGF.
HZ401837 - JP 2015177801-A/1548: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419934 - JP 2014094020-A/11: IRNA AGENTS TARGETING VEGF.
LZ247105 - JP 2016135144-A/11: IRNA AGENTS TARGETING VEGF.
FW553376 - IRNA AGENTS TARGETING VEGF.
HI963082 - Sequence 12 from Patent EP1735009.
HV496321 - JP 2011518117-A/1549: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982704 - JP 2011188866-A/12: IRNA AGENTS TARGETING VEGF.
HZ401838 - JP 2015177801-A/1549: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419935 - JP 2014094020-A/12: IRNA AGENTS TARGETING VEGF.
LZ247106 - JP 2016135144-A/12: IRNA AGENTS TARGETING VEGF.
FW553377 - IRNA AGENTS TARGETING VEGF.
HI963083 - Sequence 13 from Patent EP1735009.
HV496322 - JP 2011518117-A/1550: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982705 - JP 2011188866-A/13: IRNA AGENTS TARGETING VEGF.
HZ401839 - JP 2015177801-A/1550: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419936 - JP 2014094020-A/13: IRNA AGENTS TARGETING VEGF.
LZ247107 - JP 2016135144-A/13: IRNA AGENTS TARGETING VEGF.
FW553378 - IRNA AGENTS TARGETING VEGF.
HI963084 - Sequence 14 from Patent EP1735009.
HV496323 - JP 2011518117-A/1551: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982706 - JP 2011188866-A/14: IRNA AGENTS TARGETING VEGF.
HZ401840 - JP 2015177801-A/1551: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419937 - JP 2014094020-A/14: IRNA AGENTS TARGETING VEGF.
LZ247108 - JP 2016135144-A/14: IRNA AGENTS TARGETING VEGF.
FW553379 - IRNA AGENTS TARGETING VEGF.
HI963085 - Sequence 15 from Patent EP1735009.
HV496324 - JP 2011518117-A/1552: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982707 - JP 2011188866-A/15: IRNA AGENTS TARGETING VEGF.
HZ401841 - JP 2015177801-A/1552: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419938 - JP 2014094020-A/15: IRNA AGENTS TARGETING VEGF.
LZ247109 - JP 2016135144-A/15: IRNA AGENTS TARGETING VEGF.
FW553380 - IRNA AGENTS TARGETING VEGF.
HI963086 - Sequence 16 from Patent EP1735009.
HV496325 - JP 2011518117-A/1553: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982708 - JP 2011188866-A/16: IRNA AGENTS TARGETING VEGF.
HZ401842 - JP 2015177801-A/1553: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419939 - JP 2014094020-A/16: IRNA AGENTS TARGETING VEGF.
LZ247110 - JP 2016135144-A/16: IRNA AGENTS TARGETING VEGF.
FW553381 - IRNA AGENTS TARGETING VEGF.
HI963087 - Sequence 17 from Patent EP1735009.
HV496326 - JP 2011518117-A/1554: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982709 - JP 2011188866-A/17: IRNA AGENTS TARGETING VEGF.
HZ401843 - JP 2015177801-A/1554: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419940 - JP 2014094020-A/17: IRNA AGENTS TARGETING VEGF.
LZ247111 - JP 2016135144-A/17: IRNA AGENTS TARGETING VEGF.
FW553382 - IRNA AGENTS TARGETING VEGF.
HI963088 - Sequence 18 from Patent EP1735009.
HV496327 - JP 2011518117-A/1555: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982710 - JP 2011188866-A/18: IRNA AGENTS TARGETING VEGF.
HZ401844 - JP 2015177801-A/1555: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419941 - JP 2014094020-A/18: IRNA AGENTS TARGETING VEGF.
LZ247112 - JP 2016135144-A/18: IRNA AGENTS TARGETING VEGF.
FW553383 - IRNA AGENTS TARGETING VEGF.
HI963089 - Sequence 19 from Patent EP1735009.
HV496328 - JP 2011518117-A/1556: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982711 - JP 2011188866-A/19: IRNA AGENTS TARGETING VEGF.
HZ401845 - JP 2015177801-A/1556: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419942 - JP 2014094020-A/19: IRNA AGENTS TARGETING VEGF.
LZ247113 - JP 2016135144-A/19: IRNA AGENTS TARGETING VEGF.
FW553384 - IRNA AGENTS TARGETING VEGF.
HI963090 - Sequence 20 from Patent EP1735009.
HV496329 - JP 2011518117-A/1557: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982712 - JP 2011188866-A/20: IRNA AGENTS TARGETING VEGF.
HZ401846 - JP 2015177801-A/1557: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419943 - JP 2014094020-A/20: IRNA AGENTS TARGETING VEGF.
LZ247114 - JP 2016135144-A/20: IRNA AGENTS TARGETING VEGF.
FW553385 - IRNA AGENTS TARGETING VEGF.
HI963091 - Sequence 21 from Patent EP1735009.
HV496330 - JP 2011518117-A/1558: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982713 - JP 2011188866-A/21: IRNA AGENTS TARGETING VEGF.
HZ401847 - JP 2015177801-A/1558: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419944 - JP 2014094020-A/21: IRNA AGENTS TARGETING VEGF.
LZ247115 - JP 2016135144-A/21: IRNA AGENTS TARGETING VEGF.
FW553386 - IRNA AGENTS TARGETING VEGF.
HI963092 - Sequence 22 from Patent EP1735009.
HV496331 - JP 2011518117-A/1559: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982714 - JP 2011188866-A/22: IRNA AGENTS TARGETING VEGF.
HZ401848 - JP 2015177801-A/1559: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419945 - JP 2014094020-A/22: IRNA AGENTS TARGETING VEGF.
LZ247116 - JP 2016135144-A/22: IRNA AGENTS TARGETING VEGF.
FW553387 - IRNA AGENTS TARGETING VEGF.
HI963093 - Sequence 23 from Patent EP1735009.
HV496332 - JP 2011518117-A/1560: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496956 - JP 2011518117-A/2184: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982715 - JP 2011188866-A/23: IRNA AGENTS TARGETING VEGF.
HZ401849 - JP 2015177801-A/1560: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402473 - JP 2015177801-A/2184: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419946 - JP 2014094020-A/23: IRNA AGENTS TARGETING VEGF.
LZ247117 - JP 2016135144-A/23: IRNA AGENTS TARGETING VEGF.
FW553388 - IRNA AGENTS TARGETING VEGF.
HI963094 - Sequence 24 from Patent EP1735009.
HV496333 - JP 2011518117-A/1561: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982716 - JP 2011188866-A/24: IRNA AGENTS TARGETING VEGF.
HZ401850 - JP 2015177801-A/1561: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419947 - JP 2014094020-A/24: IRNA AGENTS TARGETING VEGF.
LZ247118 - JP 2016135144-A/24: IRNA AGENTS TARGETING VEGF.
DM163634 - Method for promotion of p53 expression.
FW553389 - IRNA AGENTS TARGETING VEGF.
HI963095 - Sequence 25 from Patent EP1735009.
HV496334 - JP 2011518117-A/1562: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982717 - JP 2011188866-A/25: IRNA AGENTS TARGETING VEGF.
HZ401851 - JP 2015177801-A/1562: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419948 - JP 2014094020-A/25: IRNA AGENTS TARGETING VEGF.
LZ247119 - JP 2016135144-A/25: IRNA AGENTS TARGETING VEGF.
FW553390 - IRNA AGENTS TARGETING VEGF.
HI963096 - Sequence 26 from Patent EP1735009.
HV496335 - JP 2011518117-A/1563: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982718 - JP 2011188866-A/26: IRNA AGENTS TARGETING VEGF.
HZ401852 - JP 2015177801-A/1563: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419949 - JP 2014094020-A/26: IRNA AGENTS TARGETING VEGF.
LZ247120 - JP 2016135144-A/26: IRNA AGENTS TARGETING VEGF.
FW553391 - IRNA AGENTS TARGETING VEGF.
HI963097 - Sequence 27 from Patent EP1735009.
HV496336 - JP 2011518117-A/1564: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982719 - JP 2011188866-A/27: IRNA AGENTS TARGETING VEGF.
HZ401853 - JP 2015177801-A/1564: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419950 - JP 2014094020-A/27: IRNA AGENTS TARGETING VEGF.
LZ247121 - JP 2016135144-A/27: IRNA AGENTS TARGETING VEGF.
FW553392 - IRNA AGENTS TARGETING VEGF.
HI963098 - Sequence 28 from Patent EP1735009.
HV496337 - JP 2011518117-A/1565: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982720 - JP 2011188866-A/28: IRNA AGENTS TARGETING VEGF.
HZ401854 - JP 2015177801-A/1565: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419951 - JP 2014094020-A/28: IRNA AGENTS TARGETING VEGF.
LZ247122 - JP 2016135144-A/28: IRNA AGENTS TARGETING VEGF.
FW553393 - IRNA AGENTS TARGETING VEGF.
HI963099 - Sequence 29 from Patent EP1735009.
HV496338 - JP 2011518117-A/1566: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982721 - JP 2011188866-A/29: IRNA AGENTS TARGETING VEGF.
HZ401855 - JP 2015177801-A/1566: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419952 - JP 2014094020-A/29: IRNA AGENTS TARGETING VEGF.
LZ247123 - JP 2016135144-A/29: IRNA AGENTS TARGETING VEGF.
DM163636 - Method for promotion of p53 expression.
FW553394 - IRNA AGENTS TARGETING VEGF.
HI963100 - Sequence 30 from Patent EP1735009.
HV496339 - JP 2011518117-A/1567: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982722 - JP 2011188866-A/30: IRNA AGENTS TARGETING VEGF.
HZ401856 - JP 2015177801-A/1567: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419953 - JP 2014094020-A/30: IRNA AGENTS TARGETING VEGF.
LZ247124 - JP 2016135144-A/30: IRNA AGENTS TARGETING VEGF.
FW553395 - IRNA AGENTS TARGETING VEGF.
HI963101 - Sequence 31 from Patent EP1735009.
HV496340 - JP 2011518117-A/1568: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982723 - JP 2011188866-A/31: IRNA AGENTS TARGETING VEGF.
HZ401857 - JP 2015177801-A/1568: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419954 - JP 2014094020-A/31: IRNA AGENTS TARGETING VEGF.
LZ247125 - JP 2016135144-A/31: IRNA AGENTS TARGETING VEGF.
FW553396 - IRNA AGENTS TARGETING VEGF.
HI963102 - Sequence 32 from Patent EP1735009.
HV496341 - JP 2011518117-A/1569: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982724 - JP 2011188866-A/32: IRNA AGENTS TARGETING VEGF.
HZ401858 - JP 2015177801-A/1569: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419955 - JP 2014094020-A/32: IRNA AGENTS TARGETING VEGF.
LZ247126 - JP 2016135144-A/32: IRNA AGENTS TARGETING VEGF.
FW553397 - IRNA AGENTS TARGETING VEGF.
HI963103 - Sequence 33 from Patent EP1735009.
HV496342 - JP 2011518117-A/1570: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982725 - JP 2011188866-A/33: IRNA AGENTS TARGETING VEGF.
HZ401859 - JP 2015177801-A/1570: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419956 - JP 2014094020-A/33: IRNA AGENTS TARGETING VEGF.
LZ247127 - JP 2016135144-A/33: IRNA AGENTS TARGETING VEGF.
FW553398 - IRNA AGENTS TARGETING VEGF.
HI963104 - Sequence 34 from Patent EP1735009.
HV496343 - JP 2011518117-A/1571: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982726 - JP 2011188866-A/34: IRNA AGENTS TARGETING VEGF.
HZ401860 - JP 2015177801-A/1571: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419957 - JP 2014094020-A/34: IRNA AGENTS TARGETING VEGF.
LZ247128 - JP 2016135144-A/34: IRNA AGENTS TARGETING VEGF.
FW553399 - IRNA AGENTS TARGETING VEGF.
HI963105 - Sequence 35 from Patent EP1735009.
HV496344 - JP 2011518117-A/1572: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982727 - JP 2011188866-A/35: IRNA AGENTS TARGETING VEGF.
HZ401861 - JP 2015177801-A/1572: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419958 - JP 2014094020-A/35: IRNA AGENTS TARGETING VEGF.
LZ247129 - JP 2016135144-A/35: IRNA AGENTS TARGETING VEGF.
FW553400 - IRNA AGENTS TARGETING VEGF.
HI963106 - Sequence 36 from Patent EP1735009.
HV496345 - JP 2011518117-A/1573: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982728 - JP 2011188866-A/36: IRNA AGENTS TARGETING VEGF.
HZ401862 - JP 2015177801-A/1573: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419959 - JP 2014094020-A/36: IRNA AGENTS TARGETING VEGF.
LZ247130 - JP 2016135144-A/36: IRNA AGENTS TARGETING VEGF.
FW553401 - IRNA AGENTS TARGETING VEGF.
HI963107 - Sequence 37 from Patent EP1735009.
HV496346 - JP 2011518117-A/1574: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982729 - JP 2011188866-A/37: IRNA AGENTS TARGETING VEGF.
HZ401863 - JP 2015177801-A/1574: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419960 - JP 2014094020-A/37: IRNA AGENTS TARGETING VEGF.
LZ247131 - JP 2016135144-A/37: IRNA AGENTS TARGETING VEGF.
FW553402 - IRNA AGENTS TARGETING VEGF.
HI963108 - Sequence 38 from Patent EP1735009.
HV496347 - JP 2011518117-A/1575: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982730 - JP 2011188866-A/38: IRNA AGENTS TARGETING VEGF.
HZ401864 - JP 2015177801-A/1575: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419961 - JP 2014094020-A/38: IRNA AGENTS TARGETING VEGF.
LZ247132 - JP 2016135144-A/38: IRNA AGENTS TARGETING VEGF.
FW553403 - IRNA AGENTS TARGETING VEGF.
HI963109 - Sequence 39 from Patent EP1735009.
HV496348 - JP 2011518117-A/1576: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982731 - JP 2011188866-A/39: IRNA AGENTS TARGETING VEGF.
HZ401865 - JP 2015177801-A/1576: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419962 - JP 2014094020-A/39: IRNA AGENTS TARGETING VEGF.
LZ247133 - JP 2016135144-A/39: IRNA AGENTS TARGETING VEGF.
FW553404 - IRNA AGENTS TARGETING VEGF.
HI963110 - Sequence 40 from Patent EP1735009.
HV496349 - JP 2011518117-A/1577: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982732 - JP 2011188866-A/40: IRNA AGENTS TARGETING VEGF.
HZ401866 - JP 2015177801-A/1577: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419963 - JP 2014094020-A/40: IRNA AGENTS TARGETING VEGF.
LZ247134 - JP 2016135144-A/40: IRNA AGENTS TARGETING VEGF.
FW553405 - IRNA AGENTS TARGETING VEGF.
HI963111 - Sequence 41 from Patent EP1735009.
HV496350 - JP 2011518117-A/1578: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982733 - JP 2011188866-A/41: IRNA AGENTS TARGETING VEGF.
HZ401867 - JP 2015177801-A/1578: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419964 - JP 2014094020-A/41: IRNA AGENTS TARGETING VEGF.
LZ247135 - JP 2016135144-A/41: IRNA AGENTS TARGETING VEGF.
FW553406 - IRNA AGENTS TARGETING VEGF.
HI963112 - Sequence 42 from Patent EP1735009.
HV496351 - JP 2011518117-A/1579: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982734 - JP 2011188866-A/42: IRNA AGENTS TARGETING VEGF.
HZ401868 - JP 2015177801-A/1579: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419965 - JP 2014094020-A/42: IRNA AGENTS TARGETING VEGF.
LZ247136 - JP 2016135144-A/42: IRNA AGENTS TARGETING VEGF.
FW553407 - IRNA AGENTS TARGETING VEGF.
HI963113 - Sequence 43 from Patent EP1735009.
HV496352 - JP 2011518117-A/1580: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982735 - JP 2011188866-A/43: IRNA AGENTS TARGETING VEGF.
HZ401869 - JP 2015177801-A/1580: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419966 - JP 2014094020-A/43: IRNA AGENTS TARGETING VEGF.
LZ247137 - JP 2016135144-A/43: IRNA AGENTS TARGETING VEGF.
FW553408 - IRNA AGENTS TARGETING VEGF.
HI963114 - Sequence 44 from Patent EP1735009.
HV496353 - JP 2011518117-A/1581: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982736 - JP 2011188866-A/44: IRNA AGENTS TARGETING VEGF.
HZ401870 - JP 2015177801-A/1581: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419967 - JP 2014094020-A/44: IRNA AGENTS TARGETING VEGF.
LZ247138 - JP 2016135144-A/44: IRNA AGENTS TARGETING VEGF.
FW553409 - IRNA AGENTS TARGETING VEGF.
HI963115 - Sequence 45 from Patent EP1735009.
HV496354 - JP 2011518117-A/1582: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982737 - JP 2011188866-A/45: IRNA AGENTS TARGETING VEGF.
HZ401871 - JP 2015177801-A/1582: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419968 - JP 2014094020-A/45: IRNA AGENTS TARGETING VEGF.
LZ247139 - JP 2016135144-A/45: IRNA AGENTS TARGETING VEGF.
FW553410 - IRNA AGENTS TARGETING VEGF.
HI963116 - Sequence 46 from Patent EP1735009.
HV496355 - JP 2011518117-A/1583: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982738 - JP 2011188866-A/46: IRNA AGENTS TARGETING VEGF.
HZ401872 - JP 2015177801-A/1583: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419969 - JP 2014094020-A/46: IRNA AGENTS TARGETING VEGF.
LZ247140 - JP 2016135144-A/46: IRNA AGENTS TARGETING VEGF.
FW553411 - IRNA AGENTS TARGETING VEGF.
HI963117 - Sequence 47 from Patent EP1735009.
HV496356 - JP 2011518117-A/1584: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982739 - JP 2011188866-A/47: IRNA AGENTS TARGETING VEGF.
HZ401873 - JP 2015177801-A/1584: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419970 - JP 2014094020-A/47: IRNA AGENTS TARGETING VEGF.
LZ247141 - JP 2016135144-A/47: IRNA AGENTS TARGETING VEGF.
LQ270810 - Sequence 138 from Patent WO2016071350.
AB209485 - Homo sapiens mRNA for vascular endothelial growth factor variant protein.
FW553428 - IRNA AGENTS TARGETING VEGF.
HI963134 - Sequence 64 from Patent EP1735009.
HV496373 - JP 2011518117-A/1601: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496972 - JP 2011518117-A/2200: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982756 - JP 2011188866-A/64: IRNA AGENTS TARGETING VEGF.
HZ401890 - JP 2015177801-A/1601: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402489 - JP 2015177801-A/2200: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419987 - JP 2014094020-A/64: IRNA AGENTS TARGETING VEGF.
LZ247158 - JP 2016135144-A/64: IRNA AGENTS TARGETING VEGF.
FW553429 - IRNA AGENTS TARGETING VEGF.
HI963135 - Sequence 65 from Patent EP1735009.
HV496374 - JP 2011518117-A/1602: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496973 - JP 2011518117-A/2201: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982757 - JP 2011188866-A/65: IRNA AGENTS TARGETING VEGF.
HZ401891 - JP 2015177801-A/1602: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402490 - JP 2015177801-A/2201: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419988 - JP 2014094020-A/65: IRNA AGENTS TARGETING VEGF.
LZ247159 - JP 2016135144-A/65: IRNA AGENTS TARGETING VEGF.
FW553430 - IRNA AGENTS TARGETING VEGF.
HI963136 - Sequence 66 from Patent EP1735009.
HV496375 - JP 2011518117-A/1603: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982758 - JP 2011188866-A/66: IRNA AGENTS TARGETING VEGF.
HZ401892 - JP 2015177801-A/1603: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419989 - JP 2014094020-A/66: IRNA AGENTS TARGETING VEGF.
LZ247160 - JP 2016135144-A/66: IRNA AGENTS TARGETING VEGF.
FW553431 - IRNA AGENTS TARGETING VEGF.
HI963137 - Sequence 67 from Patent EP1735009.
HV496376 - JP 2011518117-A/1604: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982759 - JP 2011188866-A/67: IRNA AGENTS TARGETING VEGF.
HZ401893 - JP 2015177801-A/1604: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419990 - JP 2014094020-A/67: IRNA AGENTS TARGETING VEGF.
LZ247161 - JP 2016135144-A/67: IRNA AGENTS TARGETING VEGF.
FW553432 - IRNA AGENTS TARGETING VEGF.
HI963138 - Sequence 68 from Patent EP1735009.
HV496377 - JP 2011518117-A/1605: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982760 - JP 2011188866-A/68: IRNA AGENTS TARGETING VEGF.
HZ401894 - JP 2015177801-A/1605: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419991 - JP 2014094020-A/68: IRNA AGENTS TARGETING VEGF.
LZ247162 - JP 2016135144-A/68: IRNA AGENTS TARGETING VEGF.
FW553433 - IRNA AGENTS TARGETING VEGF.
HI963139 - Sequence 69 from Patent EP1735009.
HV496378 - JP 2011518117-A/1606: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982761 - JP 2011188866-A/69: IRNA AGENTS TARGETING VEGF.
HZ401895 - JP 2015177801-A/1606: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419992 - JP 2014094020-A/69: IRNA AGENTS TARGETING VEGF.
LZ247163 - JP 2016135144-A/69: IRNA AGENTS TARGETING VEGF.
FW553434 - IRNA AGENTS TARGETING VEGF.
HI963140 - Sequence 70 from Patent EP1735009.
HV496379 - JP 2011518117-A/1607: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982762 - JP 2011188866-A/70: IRNA AGENTS TARGETING VEGF.
HZ401896 - JP 2015177801-A/1607: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419993 - JP 2014094020-A/70: IRNA AGENTS TARGETING VEGF.
LZ247164 - JP 2016135144-A/70: IRNA AGENTS TARGETING VEGF.
FW553435 - IRNA AGENTS TARGETING VEGF.
HI963141 - Sequence 71 from Patent EP1735009.
HV496380 - JP 2011518117-A/1608: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982763 - JP 2011188866-A/71: IRNA AGENTS TARGETING VEGF.
HZ401897 - JP 2015177801-A/1608: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419994 - JP 2014094020-A/71: IRNA AGENTS TARGETING VEGF.
LZ247165 - JP 2016135144-A/71: IRNA AGENTS TARGETING VEGF.
FW553436 - IRNA AGENTS TARGETING VEGF.
HI963142 - Sequence 72 from Patent EP1735009.
HV496381 - JP 2011518117-A/1609: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982764 - JP 2011188866-A/72: IRNA AGENTS TARGETING VEGF.
HZ401898 - JP 2015177801-A/1609: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419995 - JP 2014094020-A/72: IRNA AGENTS TARGETING VEGF.
LZ247166 - JP 2016135144-A/72: IRNA AGENTS TARGETING VEGF.
FW553437 - IRNA AGENTS TARGETING VEGF.
HI963143 - Sequence 73 from Patent EP1735009.
HV496382 - JP 2011518117-A/1610: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982765 - JP 2011188866-A/73: IRNA AGENTS TARGETING VEGF.
HZ401899 - JP 2015177801-A/1610: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419996 - JP 2014094020-A/73: IRNA AGENTS TARGETING VEGF.
LZ247167 - JP 2016135144-A/73: IRNA AGENTS TARGETING VEGF.
FW553438 - IRNA AGENTS TARGETING VEGF.
HI963144 - Sequence 74 from Patent EP1735009.
HV496383 - JP 2011518117-A/1611: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982766 - JP 2011188866-A/74: IRNA AGENTS TARGETING VEGF.
HZ401900 - JP 2015177801-A/1611: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419997 - JP 2014094020-A/74: IRNA AGENTS TARGETING VEGF.
LZ247168 - JP 2016135144-A/74: IRNA AGENTS TARGETING VEGF.
FW553439 - IRNA AGENTS TARGETING VEGF.
HI963145 - Sequence 75 from Patent EP1735009.
HV496384 - JP 2011518117-A/1612: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982767 - JP 2011188866-A/75: IRNA AGENTS TARGETING VEGF.
HZ401901 - JP 2015177801-A/1612: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419998 - JP 2014094020-A/75: IRNA AGENTS TARGETING VEGF.
LZ247169 - JP 2016135144-A/75: IRNA AGENTS TARGETING VEGF.
FW553440 - IRNA AGENTS TARGETING VEGF.
HI963146 - Sequence 76 from Patent EP1735009.
HV496385 - JP 2011518117-A/1613: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982768 - JP 2011188866-A/76: IRNA AGENTS TARGETING VEGF.
HZ401902 - JP 2015177801-A/1613: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ419999 - JP 2014094020-A/76: IRNA AGENTS TARGETING VEGF.
LZ247170 - JP 2016135144-A/76: IRNA AGENTS TARGETING VEGF.
KT581010 - Homo sapiens vascular endothelial growth factor A121 mRNA, partial cds.
FW553453 - IRNA AGENTS TARGETING VEGF.
HI963159 - Sequence 89 from Patent EP1735009.
HV496398 - JP 2011518117-A/1626: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982781 - JP 2011188866-A/89: IRNA AGENTS TARGETING VEGF.
HZ401915 - JP 2015177801-A/1626: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420012 - JP 2014094020-A/89: IRNA AGENTS TARGETING VEGF.
LZ247183 - JP 2016135144-A/89: IRNA AGENTS TARGETING VEGF.
FW553454 - IRNA AGENTS TARGETING VEGF.
HI963160 - Sequence 90 from Patent EP1735009.
HV496399 - JP 2011518117-A/1627: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982782 - JP 2011188866-A/90: IRNA AGENTS TARGETING VEGF.
HZ401916 - JP 2015177801-A/1627: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420013 - JP 2014094020-A/90: IRNA AGENTS TARGETING VEGF.
LZ247184 - JP 2016135144-A/90: IRNA AGENTS TARGETING VEGF.
FW553455 - IRNA AGENTS TARGETING VEGF.
HI963161 - Sequence 91 from Patent EP1735009.
HV496400 - JP 2011518117-A/1628: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982783 - JP 2011188866-A/91: IRNA AGENTS TARGETING VEGF.
HZ401917 - JP 2015177801-A/1628: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420014 - JP 2014094020-A/91: IRNA AGENTS TARGETING VEGF.
LZ247185 - JP 2016135144-A/91: IRNA AGENTS TARGETING VEGF.
FW553456 - IRNA AGENTS TARGETING VEGF.
HI963162 - Sequence 92 from Patent EP1735009.
HV496401 - JP 2011518117-A/1629: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982784 - JP 2011188866-A/92: IRNA AGENTS TARGETING VEGF.
HZ401918 - JP 2015177801-A/1629: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420015 - JP 2014094020-A/92: IRNA AGENTS TARGETING VEGF.
LZ247186 - JP 2016135144-A/92: IRNA AGENTS TARGETING VEGF.
FW553457 - IRNA AGENTS TARGETING VEGF.
HI963163 - Sequence 93 from Patent EP1735009.
HV496402 - JP 2011518117-A/1630: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982785 - JP 2011188866-A/93: IRNA AGENTS TARGETING VEGF.
HZ401919 - JP 2015177801-A/1630: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420016 - JP 2014094020-A/93: IRNA AGENTS TARGETING VEGF.
LZ247187 - JP 2016135144-A/93: IRNA AGENTS TARGETING VEGF.
FW553458 - IRNA AGENTS TARGETING VEGF.
HI963164 - Sequence 94 from Patent EP1735009.
HV496403 - JP 2011518117-A/1631: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982786 - JP 2011188866-A/94: IRNA AGENTS TARGETING VEGF.
HZ401920 - JP 2015177801-A/1631: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420017 - JP 2014094020-A/94: IRNA AGENTS TARGETING VEGF.
LZ247188 - JP 2016135144-A/94: IRNA AGENTS TARGETING VEGF.
FW553459 - IRNA AGENTS TARGETING VEGF.
HI963165 - Sequence 95 from Patent EP1735009.
HV496404 - JP 2011518117-A/1632: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982787 - JP 2011188866-A/95: IRNA AGENTS TARGETING VEGF.
HZ401921 - JP 2015177801-A/1632: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420018 - JP 2014094020-A/95: IRNA AGENTS TARGETING VEGF.
LZ247189 - JP 2016135144-A/95: IRNA AGENTS TARGETING VEGF.
FW553460 - IRNA AGENTS TARGETING VEGF.
HI963166 - Sequence 96 from Patent EP1735009.
HV496405 - JP 2011518117-A/1633: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982788 - JP 2011188866-A/96: IRNA AGENTS TARGETING VEGF.
HZ401922 - JP 2015177801-A/1633: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420019 - JP 2014094020-A/96: IRNA AGENTS TARGETING VEGF.
LZ247190 - JP 2016135144-A/96: IRNA AGENTS TARGETING VEGF.
FW553461 - IRNA AGENTS TARGETING VEGF.
HI963167 - Sequence 97 from Patent EP1735009.
HV496406 - JP 2011518117-A/1634: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982789 - JP 2011188866-A/97: IRNA AGENTS TARGETING VEGF.
HZ401923 - JP 2015177801-A/1634: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420020 - JP 2014094020-A/97: IRNA AGENTS TARGETING VEGF.
LZ247191 - JP 2016135144-A/97: IRNA AGENTS TARGETING VEGF.
FW553462 - IRNA AGENTS TARGETING VEGF.
HI963168 - Sequence 98 from Patent EP1735009.
HV496407 - JP 2011518117-A/1635: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982790 - JP 2011188866-A/98: IRNA AGENTS TARGETING VEGF.
HZ401924 - JP 2015177801-A/1635: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420021 - JP 2014094020-A/98: IRNA AGENTS TARGETING VEGF.
LZ247192 - JP 2016135144-A/98: IRNA AGENTS TARGETING VEGF.
FW553463 - IRNA AGENTS TARGETING VEGF.
HI963169 - Sequence 99 from Patent EP1735009.
HV496408 - JP 2011518117-A/1636: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982791 - JP 2011188866-A/99: IRNA AGENTS TARGETING VEGF.
HZ401925 - JP 2015177801-A/1636: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420022 - JP 2014094020-A/99: IRNA AGENTS TARGETING VEGF.
LZ247193 - JP 2016135144-A/99: IRNA AGENTS TARGETING VEGF.
AK056914 - Homo sapiens cDNA FLJ32352 fis, clone PROST2007389, moderately similar to VASCULAR ENDOTHELIAL GROWTH FACTOR PRECURSOR.
FW553480 - IRNA AGENTS TARGETING VEGF.
HI963186 - Sequence 116 from Patent EP1735009.
HV496425 - JP 2011518117-A/1653: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982808 - JP 2011188866-A/116: IRNA AGENTS TARGETING VEGF.
HZ401942 - JP 2015177801-A/1653: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420039 - JP 2014094020-A/116: IRNA AGENTS TARGETING VEGF.
LZ247210 - JP 2016135144-A/116: IRNA AGENTS TARGETING VEGF.
FW553481 - IRNA AGENTS TARGETING VEGF.
HI963187 - Sequence 117 from Patent EP1735009.
HV496426 - JP 2011518117-A/1654: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982809 - JP 2011188866-A/117: IRNA AGENTS TARGETING VEGF.
HZ401943 - JP 2015177801-A/1654: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420040 - JP 2014094020-A/117: IRNA AGENTS TARGETING VEGF.
LZ247211 - JP 2016135144-A/117: IRNA AGENTS TARGETING VEGF.
FW553482 - IRNA AGENTS TARGETING VEGF.
HI963188 - Sequence 118 from Patent EP1735009.
HV496427 - JP 2011518117-A/1655: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982810 - JP 2011188866-A/118: IRNA AGENTS TARGETING VEGF.
HZ401944 - JP 2015177801-A/1655: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420041 - JP 2014094020-A/118: IRNA AGENTS TARGETING VEGF.
LZ247212 - JP 2016135144-A/118: IRNA AGENTS TARGETING VEGF.
FW553483 - IRNA AGENTS TARGETING VEGF.
HI963189 - Sequence 119 from Patent EP1735009.
HV496428 - JP 2011518117-A/1656: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982811 - JP 2011188866-A/119: IRNA AGENTS TARGETING VEGF.
HZ401945 - JP 2015177801-A/1656: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420042 - JP 2014094020-A/119: IRNA AGENTS TARGETING VEGF.
LZ247213 - JP 2016135144-A/119: IRNA AGENTS TARGETING VEGF.
FW553484 - IRNA AGENTS TARGETING VEGF.
HI963190 - Sequence 120 from Patent EP1735009.
HV496429 - JP 2011518117-A/1657: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982812 - JP 2011188866-A/120: IRNA AGENTS TARGETING VEGF.
HZ401946 - JP 2015177801-A/1657: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420043 - JP 2014094020-A/120: IRNA AGENTS TARGETING VEGF.
LZ247214 - JP 2016135144-A/120: IRNA AGENTS TARGETING VEGF.
FW553485 - IRNA AGENTS TARGETING VEGF.
HI963191 - Sequence 121 from Patent EP1735009.
HV496430 - JP 2011518117-A/1658: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982813 - JP 2011188866-A/121: IRNA AGENTS TARGETING VEGF.
HZ401947 - JP 2015177801-A/1658: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420044 - JP 2014094020-A/121: IRNA AGENTS TARGETING VEGF.
LZ247215 - JP 2016135144-A/121: IRNA AGENTS TARGETING VEGF.
FW553486 - IRNA AGENTS TARGETING VEGF.
HI963192 - Sequence 122 from Patent EP1735009.
HV496431 - JP 2011518117-A/1659: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496982 - JP 2011518117-A/2210: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982814 - JP 2011188866-A/122: IRNA AGENTS TARGETING VEGF.
HZ401948 - JP 2015177801-A/1659: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402499 - JP 2015177801-A/2210: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420045 - JP 2014094020-A/122: IRNA AGENTS TARGETING VEGF.
LZ247216 - JP 2016135144-A/122: IRNA AGENTS TARGETING VEGF.
FW553487 - IRNA AGENTS TARGETING VEGF.
HI963193 - Sequence 123 from Patent EP1735009.
HV496432 - JP 2011518117-A/1660: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982815 - JP 2011188866-A/123: IRNA AGENTS TARGETING VEGF.
HZ401949 - JP 2015177801-A/1660: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420046 - JP 2014094020-A/123: IRNA AGENTS TARGETING VEGF.
LZ247217 - JP 2016135144-A/123: IRNA AGENTS TARGETING VEGF.
FW553488 - IRNA AGENTS TARGETING VEGF.
HI963194 - Sequence 124 from Patent EP1735009.
HV496433 - JP 2011518117-A/1661: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982816 - JP 2011188866-A/124: IRNA AGENTS TARGETING VEGF.
HZ401950 - JP 2015177801-A/1661: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420047 - JP 2014094020-A/124: IRNA AGENTS TARGETING VEGF.
LZ247218 - JP 2016135144-A/124: IRNA AGENTS TARGETING VEGF.
FW553489 - IRNA AGENTS TARGETING VEGF.
HI963195 - Sequence 125 from Patent EP1735009.
HV496434 - JP 2011518117-A/1662: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982817 - JP 2011188866-A/125: IRNA AGENTS TARGETING VEGF.
HZ401951 - JP 2015177801-A/1662: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420048 - JP 2014094020-A/125: IRNA AGENTS TARGETING VEGF.
LZ247219 - JP 2016135144-A/125: IRNA AGENTS TARGETING VEGF.
FW553490 - IRNA AGENTS TARGETING VEGF.
HI963196 - Sequence 126 from Patent EP1735009.
HV496435 - JP 2011518117-A/1663: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982818 - JP 2011188866-A/126: IRNA AGENTS TARGETING VEGF.
HZ401952 - JP 2015177801-A/1663: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420049 - JP 2014094020-A/126: IRNA AGENTS TARGETING VEGF.
LZ247220 - JP 2016135144-A/126: IRNA AGENTS TARGETING VEGF.
FW553491 - IRNA AGENTS TARGETING VEGF.
HI963197 - Sequence 127 from Patent EP1735009.
HV496436 - JP 2011518117-A/1664: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982819 - JP 2011188866-A/127: IRNA AGENTS TARGETING VEGF.
HZ401953 - JP 2015177801-A/1664: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420050 - JP 2014094020-A/127: IRNA AGENTS TARGETING VEGF.
LZ247221 - JP 2016135144-A/127: IRNA AGENTS TARGETING VEGF.
FW553492 - IRNA AGENTS TARGETING VEGF.
HI963198 - Sequence 128 from Patent EP1735009.
HV496437 - JP 2011518117-A/1665: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982820 - JP 2011188866-A/128: IRNA AGENTS TARGETING VEGF.
HZ401954 - JP 2015177801-A/1665: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420051 - JP 2014094020-A/128: IRNA AGENTS TARGETING VEGF.
LZ247222 - JP 2016135144-A/128: IRNA AGENTS TARGETING VEGF.
FW553493 - IRNA AGENTS TARGETING VEGF.
HI963199 - Sequence 129 from Patent EP1735009.
HV496438 - JP 2011518117-A/1666: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982821 - JP 2011188866-A/129: IRNA AGENTS TARGETING VEGF.
HZ401955 - JP 2015177801-A/1666: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420052 - JP 2014094020-A/129: IRNA AGENTS TARGETING VEGF.
LZ247223 - JP 2016135144-A/129: IRNA AGENTS TARGETING VEGF.
FW553494 - IRNA AGENTS TARGETING VEGF.
HI963200 - Sequence 130 from Patent EP1735009.
HV496439 - JP 2011518117-A/1667: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496983 - JP 2011518117-A/2211: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982822 - JP 2011188866-A/130: IRNA AGENTS TARGETING VEGF.
HZ401956 - JP 2015177801-A/1667: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402500 - JP 2015177801-A/2211: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420053 - JP 2014094020-A/130: IRNA AGENTS TARGETING VEGF.
LZ247224 - JP 2016135144-A/130: IRNA AGENTS TARGETING VEGF.
FW553495 - IRNA AGENTS TARGETING VEGF.
HI963201 - Sequence 131 from Patent EP1735009.
HV496440 - JP 2011518117-A/1668: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496984 - JP 2011518117-A/2212: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982823 - JP 2011188866-A/131: IRNA AGENTS TARGETING VEGF.
HZ401957 - JP 2015177801-A/1668: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402501 - JP 2015177801-A/2212: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420054 - JP 2014094020-A/131: IRNA AGENTS TARGETING VEGF.
LZ247225 - JP 2016135144-A/131: IRNA AGENTS TARGETING VEGF.
FW553496 - IRNA AGENTS TARGETING VEGF.
HI963202 - Sequence 132 from Patent EP1735009.
HV496441 - JP 2011518117-A/1669: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496985 - JP 2011518117-A/2213: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982824 - JP 2011188866-A/132: IRNA AGENTS TARGETING VEGF.
HZ401958 - JP 2015177801-A/1669: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402502 - JP 2015177801-A/2213: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420055 - JP 2014094020-A/132: IRNA AGENTS TARGETING VEGF.
LZ247226 - JP 2016135144-A/132: IRNA AGENTS TARGETING VEGF.
FW553497 - IRNA AGENTS TARGETING VEGF.
HI963203 - Sequence 133 from Patent EP1735009.
HV496442 - JP 2011518117-A/1670: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496986 - JP 2011518117-A/2214: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982825 - JP 2011188866-A/133: IRNA AGENTS TARGETING VEGF.
HZ401959 - JP 2015177801-A/1670: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402503 - JP 2015177801-A/2214: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420056 - JP 2014094020-A/133: IRNA AGENTS TARGETING VEGF.
LZ247227 - JP 2016135144-A/133: IRNA AGENTS TARGETING VEGF.
FW553498 - IRNA AGENTS TARGETING VEGF.
HI963204 - Sequence 134 from Patent EP1735009.
HV496443 - JP 2011518117-A/1671: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496987 - JP 2011518117-A/2215: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982826 - JP 2011188866-A/134: IRNA AGENTS TARGETING VEGF.
HZ401960 - JP 2015177801-A/1671: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402504 - JP 2015177801-A/2215: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420057 - JP 2014094020-A/134: IRNA AGENTS TARGETING VEGF.
LZ247228 - JP 2016135144-A/134: IRNA AGENTS TARGETING VEGF.
FW553499 - IRNA AGENTS TARGETING VEGF.
HI963205 - Sequence 135 from Patent EP1735009.
HV496444 - JP 2011518117-A/1672: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496988 - JP 2011518117-A/2216: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982827 - JP 2011188866-A/135: IRNA AGENTS TARGETING VEGF.
HZ401961 - JP 2015177801-A/1672: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402505 - JP 2015177801-A/2216: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420058 - JP 2014094020-A/135: IRNA AGENTS TARGETING VEGF.
LZ247229 - JP 2016135144-A/135: IRNA AGENTS TARGETING VEGF.
FW553500 - IRNA AGENTS TARGETING VEGF.
HI963206 - Sequence 136 from Patent EP1735009.
HV496445 - JP 2011518117-A/1673: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496989 - JP 2011518117-A/2217: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982828 - JP 2011188866-A/136: IRNA AGENTS TARGETING VEGF.
HZ401962 - JP 2015177801-A/1673: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402506 - JP 2015177801-A/2217: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420059 - JP 2014094020-A/136: IRNA AGENTS TARGETING VEGF.
LZ247230 - JP 2016135144-A/136: IRNA AGENTS TARGETING VEGF.
FW553501 - IRNA AGENTS TARGETING VEGF.
HI963207 - Sequence 137 from Patent EP1735009.
HV496446 - JP 2011518117-A/1674: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982829 - JP 2011188866-A/137: IRNA AGENTS TARGETING VEGF.
HZ401963 - JP 2015177801-A/1674: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420060 - JP 2014094020-A/137: IRNA AGENTS TARGETING VEGF.
LZ247231 - JP 2016135144-A/137: IRNA AGENTS TARGETING VEGF.
FW553502 - IRNA AGENTS TARGETING VEGF.
HI963208 - Sequence 138 from Patent EP1735009.
HV496447 - JP 2011518117-A/1675: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982830 - JP 2011188866-A/138: IRNA AGENTS TARGETING VEGF.
HZ401964 - JP 2015177801-A/1675: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420061 - JP 2014094020-A/138: IRNA AGENTS TARGETING VEGF.
LZ247232 - JP 2016135144-A/138: IRNA AGENTS TARGETING VEGF.
FW553503 - IRNA AGENTS TARGETING VEGF.
HI963209 - Sequence 139 from Patent EP1735009.
HV496448 - JP 2011518117-A/1676: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982831 - JP 2011188866-A/139: IRNA AGENTS TARGETING VEGF.
HZ401965 - JP 2015177801-A/1676: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420062 - JP 2014094020-A/139: IRNA AGENTS TARGETING VEGF.
LZ247233 - JP 2016135144-A/139: IRNA AGENTS TARGETING VEGF.
FW553504 - IRNA AGENTS TARGETING VEGF.
HI963210 - Sequence 140 from Patent EP1735009.
HV496449 - JP 2011518117-A/1677: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982832 - JP 2011188866-A/140: IRNA AGENTS TARGETING VEGF.
HZ401966 - JP 2015177801-A/1677: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420063 - JP 2014094020-A/140: IRNA AGENTS TARGETING VEGF.
LZ247234 - JP 2016135144-A/140: IRNA AGENTS TARGETING VEGF.
FW553505 - IRNA AGENTS TARGETING VEGF.
HI963211 - Sequence 141 from Patent EP1735009.
HV496450 - JP 2011518117-A/1678: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982833 - JP 2011188866-A/141: IRNA AGENTS TARGETING VEGF.
HZ401967 - JP 2015177801-A/1678: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420064 - JP 2014094020-A/141: IRNA AGENTS TARGETING VEGF.
LZ247235 - JP 2016135144-A/141: IRNA AGENTS TARGETING VEGF.
FW553506 - IRNA AGENTS TARGETING VEGF.
HI963212 - Sequence 142 from Patent EP1735009.
HV496451 - JP 2011518117-A/1679: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982834 - JP 2011188866-A/142: IRNA AGENTS TARGETING VEGF.
HZ401968 - JP 2015177801-A/1679: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420065 - JP 2014094020-A/142: IRNA AGENTS TARGETING VEGF.
LZ247236 - JP 2016135144-A/142: IRNA AGENTS TARGETING VEGF.
FW553507 - IRNA AGENTS TARGETING VEGF.
HI963213 - Sequence 143 from Patent EP1735009.
HV496452 - JP 2011518117-A/1680: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982835 - JP 2011188866-A/143: IRNA AGENTS TARGETING VEGF.
HZ401969 - JP 2015177801-A/1680: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420066 - JP 2014094020-A/143: IRNA AGENTS TARGETING VEGF.
LZ247237 - JP 2016135144-A/143: IRNA AGENTS TARGETING VEGF.
FW553508 - IRNA AGENTS TARGETING VEGF.
HI963214 - Sequence 144 from Patent EP1735009.
HV496453 - JP 2011518117-A/1681: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982836 - JP 2011188866-A/144: IRNA AGENTS TARGETING VEGF.
HZ401970 - JP 2015177801-A/1681: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420067 - JP 2014094020-A/144: IRNA AGENTS TARGETING VEGF.
LZ247238 - JP 2016135144-A/144: IRNA AGENTS TARGETING VEGF.
FW553509 - IRNA AGENTS TARGETING VEGF.
HI963215 - Sequence 145 from Patent EP1735009.
HV496454 - JP 2011518117-A/1682: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496990 - JP 2011518117-A/2218: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982837 - JP 2011188866-A/145: IRNA AGENTS TARGETING VEGF.
HZ401971 - JP 2015177801-A/1682: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402507 - JP 2015177801-A/2218: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420068 - JP 2014094020-A/145: IRNA AGENTS TARGETING VEGF.
LZ247239 - JP 2016135144-A/145: IRNA AGENTS TARGETING VEGF.
FW553510 - IRNA AGENTS TARGETING VEGF.
HI963216 - Sequence 146 from Patent EP1735009.
HV496455 - JP 2011518117-A/1683: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982838 - JP 2011188866-A/146: IRNA AGENTS TARGETING VEGF.
HZ401972 - JP 2015177801-A/1683: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420069 - JP 2014094020-A/146: IRNA AGENTS TARGETING VEGF.
LZ247240 - JP 2016135144-A/146: IRNA AGENTS TARGETING VEGF.
FW553511 - IRNA AGENTS TARGETING VEGF.
HI963217 - Sequence 147 from Patent EP1735009.
HV496456 - JP 2011518117-A/1684: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496991 - JP 2011518117-A/2219: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982839 - JP 2011188866-A/147: IRNA AGENTS TARGETING VEGF.
HZ401973 - JP 2015177801-A/1684: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402508 - JP 2015177801-A/2219: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420070 - JP 2014094020-A/147: IRNA AGENTS TARGETING VEGF.
LZ247241 - JP 2016135144-A/147: IRNA AGENTS TARGETING VEGF.
FW553512 - IRNA AGENTS TARGETING VEGF.
HI963218 - Sequence 148 from Patent EP1735009.
HV496457 - JP 2011518117-A/1685: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982840 - JP 2011188866-A/148: IRNA AGENTS TARGETING VEGF.
HZ401974 - JP 2015177801-A/1685: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420071 - JP 2014094020-A/148: IRNA AGENTS TARGETING VEGF.
LZ247242 - JP 2016135144-A/148: IRNA AGENTS TARGETING VEGF.
FW553513 - IRNA AGENTS TARGETING VEGF.
HI963219 - Sequence 149 from Patent EP1735009.
HV496458 - JP 2011518117-A/1686: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982841 - JP 2011188866-A/149: IRNA AGENTS TARGETING VEGF.
HZ401975 - JP 2015177801-A/1686: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420072 - JP 2014094020-A/149: IRNA AGENTS TARGETING VEGF.
LZ247243 - JP 2016135144-A/149: IRNA AGENTS TARGETING VEGF.
FW553514 - IRNA AGENTS TARGETING VEGF.
HI963220 - Sequence 150 from Patent EP1735009.
HV496459 - JP 2011518117-A/1687: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496992 - JP 2011518117-A/2220: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982842 - JP 2011188866-A/150: IRNA AGENTS TARGETING VEGF.
HZ401976 - JP 2015177801-A/1687: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402509 - JP 2015177801-A/2220: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420073 - JP 2014094020-A/150: IRNA AGENTS TARGETING VEGF.
LZ247244 - JP 2016135144-A/150: IRNA AGENTS TARGETING VEGF.
FW553515 - IRNA AGENTS TARGETING VEGF.
HI963221 - Sequence 151 from Patent EP1735009.
HV496460 - JP 2011518117-A/1688: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496993 - JP 2011518117-A/2221: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982843 - JP 2011188866-A/151: IRNA AGENTS TARGETING VEGF.
HZ401977 - JP 2015177801-A/1688: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402510 - JP 2015177801-A/2221: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420074 - JP 2014094020-A/151: IRNA AGENTS TARGETING VEGF.
LZ247245 - JP 2016135144-A/151: IRNA AGENTS TARGETING VEGF.
FW553516 - IRNA AGENTS TARGETING VEGF.
HI963222 - Sequence 152 from Patent EP1735009.
HV496461 - JP 2011518117-A/1689: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496994 - JP 2011518117-A/2222: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982844 - JP 2011188866-A/152: IRNA AGENTS TARGETING VEGF.
HZ401978 - JP 2015177801-A/1689: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402511 - JP 2015177801-A/2222: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420075 - JP 2014094020-A/152: IRNA AGENTS TARGETING VEGF.
LZ247246 - JP 2016135144-A/152: IRNA AGENTS TARGETING VEGF.
FW553517 - IRNA AGENTS TARGETING VEGF.
HI963223 - Sequence 153 from Patent EP1735009.
HV496462 - JP 2011518117-A/1690: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496995 - JP 2011518117-A/2223: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982845 - JP 2011188866-A/153: IRNA AGENTS TARGETING VEGF.
HZ401979 - JP 2015177801-A/1690: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402512 - JP 2015177801-A/2223: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420076 - JP 2014094020-A/153: IRNA AGENTS TARGETING VEGF.
LZ247247 - JP 2016135144-A/153: IRNA AGENTS TARGETING VEGF.
FW553518 - IRNA AGENTS TARGETING VEGF.
HI963224 - Sequence 154 from Patent EP1735009.
HV496463 - JP 2011518117-A/1691: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982846 - JP 2011188866-A/154: IRNA AGENTS TARGETING VEGF.
HZ401980 - JP 2015177801-A/1691: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420077 - JP 2014094020-A/154: IRNA AGENTS TARGETING VEGF.
LZ247248 - JP 2016135144-A/154: IRNA AGENTS TARGETING VEGF.
FW553519 - IRNA AGENTS TARGETING VEGF.
HI963225 - Sequence 155 from Patent EP1735009.
HV496464 - JP 2011518117-A/1692: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982847 - JP 2011188866-A/155: IRNA AGENTS TARGETING VEGF.
HZ401981 - JP 2015177801-A/1692: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420078 - JP 2014094020-A/155: IRNA AGENTS TARGETING VEGF.
LZ247249 - JP 2016135144-A/155: IRNA AGENTS TARGETING VEGF.
FW553520 - IRNA AGENTS TARGETING VEGF.
HI963226 - Sequence 156 from Patent EP1735009.
HV496465 - JP 2011518117-A/1693: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982848 - JP 2011188866-A/156: IRNA AGENTS TARGETING VEGF.
HZ401982 - JP 2015177801-A/1693: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420079 - JP 2014094020-A/156: IRNA AGENTS TARGETING VEGF.
LZ247250 - JP 2016135144-A/156: IRNA AGENTS TARGETING VEGF.
FW553521 - IRNA AGENTS TARGETING VEGF.
HI963227 - Sequence 157 from Patent EP1735009.
HV496466 - JP 2011518117-A/1694: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982849 - JP 2011188866-A/157: IRNA AGENTS TARGETING VEGF.
HZ401983 - JP 2015177801-A/1694: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420080 - JP 2014094020-A/157: IRNA AGENTS TARGETING VEGF.
LZ247251 - JP 2016135144-A/157: IRNA AGENTS TARGETING VEGF.
FW553522 - IRNA AGENTS TARGETING VEGF.
HI963228 - Sequence 158 from Patent EP1735009.
HV496467 - JP 2011518117-A/1695: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982850 - JP 2011188866-A/158: IRNA AGENTS TARGETING VEGF.
HZ401984 - JP 2015177801-A/1695: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420081 - JP 2014094020-A/158: IRNA AGENTS TARGETING VEGF.
LZ247252 - JP 2016135144-A/158: IRNA AGENTS TARGETING VEGF.
FW553523 - IRNA AGENTS TARGETING VEGF.
HI963229 - Sequence 159 from Patent EP1735009.
HV496468 - JP 2011518117-A/1696: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982851 - JP 2011188866-A/159: IRNA AGENTS TARGETING VEGF.
HZ401985 - JP 2015177801-A/1696: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420082 - JP 2014094020-A/159: IRNA AGENTS TARGETING VEGF.
LZ247253 - JP 2016135144-A/159: IRNA AGENTS TARGETING VEGF.
FW553524 - IRNA AGENTS TARGETING VEGF.
HI963230 - Sequence 160 from Patent EP1735009.
HV496469 - JP 2011518117-A/1697: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982852 - JP 2011188866-A/160: IRNA AGENTS TARGETING VEGF.
HZ401986 - JP 2015177801-A/1697: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420083 - JP 2014094020-A/160: IRNA AGENTS TARGETING VEGF.
LZ247254 - JP 2016135144-A/160: IRNA AGENTS TARGETING VEGF.
FW553525 - IRNA AGENTS TARGETING VEGF.
HI963231 - Sequence 161 from Patent EP1735009.
HV496470 - JP 2011518117-A/1698: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982853 - JP 2011188866-A/161: IRNA AGENTS TARGETING VEGF.
HZ401987 - JP 2015177801-A/1698: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420084 - JP 2014094020-A/161: IRNA AGENTS TARGETING VEGF.
LZ247255 - JP 2016135144-A/161: IRNA AGENTS TARGETING VEGF.
FW553526 - IRNA AGENTS TARGETING VEGF.
HI963232 - Sequence 162 from Patent EP1735009.
HV496471 - JP 2011518117-A/1699: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982854 - JP 2011188866-A/162: IRNA AGENTS TARGETING VEGF.
HZ401988 - JP 2015177801-A/1699: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420085 - JP 2014094020-A/162: IRNA AGENTS TARGETING VEGF.
LZ247256 - JP 2016135144-A/162: IRNA AGENTS TARGETING VEGF.
FW553527 - IRNA AGENTS TARGETING VEGF.
HI963233 - Sequence 163 from Patent EP1735009.
HV496472 - JP 2011518117-A/1700: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982855 - JP 2011188866-A/163: IRNA AGENTS TARGETING VEGF.
HZ401989 - JP 2015177801-A/1700: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420086 - JP 2014094020-A/163: IRNA AGENTS TARGETING VEGF.
LZ247257 - JP 2016135144-A/163: IRNA AGENTS TARGETING VEGF.
FW553528 - IRNA AGENTS TARGETING VEGF.
HI963234 - Sequence 164 from Patent EP1735009.
HV496473 - JP 2011518117-A/1701: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982856 - JP 2011188866-A/164: IRNA AGENTS TARGETING VEGF.
HZ401990 - JP 2015177801-A/1701: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420087 - JP 2014094020-A/164: IRNA AGENTS TARGETING VEGF.
LZ247258 - JP 2016135144-A/164: IRNA AGENTS TARGETING VEGF.
FW553529 - IRNA AGENTS TARGETING VEGF.
HI963235 - Sequence 165 from Patent EP1735009.
HV496474 - JP 2011518117-A/1702: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982857 - JP 2011188866-A/165: IRNA AGENTS TARGETING VEGF.
HZ401991 - JP 2015177801-A/1702: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420088 - JP 2014094020-A/165: IRNA AGENTS TARGETING VEGF.
LZ247259 - JP 2016135144-A/165: IRNA AGENTS TARGETING VEGF.
FW553530 - IRNA AGENTS TARGETING VEGF.
HI963236 - Sequence 166 from Patent EP1735009.
HV496475 - JP 2011518117-A/1703: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982858 - JP 2011188866-A/166: IRNA AGENTS TARGETING VEGF.
HZ401992 - JP 2015177801-A/1703: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420089 - JP 2014094020-A/166: IRNA AGENTS TARGETING VEGF.
LZ247260 - JP 2016135144-A/166: IRNA AGENTS TARGETING VEGF.
FW553531 - IRNA AGENTS TARGETING VEGF.
HI963237 - Sequence 167 from Patent EP1735009.
HV496476 - JP 2011518117-A/1704: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496996 - JP 2011518117-A/2224: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982859 - JP 2011188866-A/167: IRNA AGENTS TARGETING VEGF.
HZ401993 - JP 2015177801-A/1704: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402513 - JP 2015177801-A/2224: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420090 - JP 2014094020-A/167: IRNA AGENTS TARGETING VEGF.
LZ247261 - JP 2016135144-A/167: IRNA AGENTS TARGETING VEGF.
FW553532 - IRNA AGENTS TARGETING VEGF.
HI963238 - Sequence 168 from Patent EP1735009.
HV496477 - JP 2011518117-A/1705: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496997 - JP 2011518117-A/2225: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982860 - JP 2011188866-A/168: IRNA AGENTS TARGETING VEGF.
HZ401994 - JP 2015177801-A/1705: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402514 - JP 2015177801-A/2225: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420091 - JP 2014094020-A/168: IRNA AGENTS TARGETING VEGF.
LZ247262 - JP 2016135144-A/168: IRNA AGENTS TARGETING VEGF.
FW553533 - IRNA AGENTS TARGETING VEGF.
HI963239 - Sequence 169 from Patent EP1735009.
HV496478 - JP 2011518117-A/1706: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496998 - JP 2011518117-A/2226: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982861 - JP 2011188866-A/169: IRNA AGENTS TARGETING VEGF.
HZ401995 - JP 2015177801-A/1706: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402515 - JP 2015177801-A/2226: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420092 - JP 2014094020-A/169: IRNA AGENTS TARGETING VEGF.
LZ247263 - JP 2016135144-A/169: IRNA AGENTS TARGETING VEGF.
FW553534 - IRNA AGENTS TARGETING VEGF.
HI963240 - Sequence 170 from Patent EP1735009.
HV496479 - JP 2011518117-A/1707: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV496999 - JP 2011518117-A/2227: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982862 - JP 2011188866-A/170: IRNA AGENTS TARGETING VEGF.
HZ401996 - JP 2015177801-A/1707: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402516 - JP 2015177801-A/2227: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420093 - JP 2014094020-A/170: IRNA AGENTS TARGETING VEGF.
LZ247264 - JP 2016135144-A/170: IRNA AGENTS TARGETING VEGF.
FW553535 - IRNA AGENTS TARGETING VEGF.
HI963241 - Sequence 171 from Patent EP1735009.
HV496480 - JP 2011518117-A/1708: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497000 - JP 2011518117-A/2228: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982863 - JP 2011188866-A/171: IRNA AGENTS TARGETING VEGF.
HZ401997 - JP 2015177801-A/1708: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402517 - JP 2015177801-A/2228: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420094 - JP 2014094020-A/171: IRNA AGENTS TARGETING VEGF.
LZ247265 - JP 2016135144-A/171: IRNA AGENTS TARGETING VEGF.
FW553536 - IRNA AGENTS TARGETING VEGF.
HI963242 - Sequence 172 from Patent EP1735009.
HV496481 - JP 2011518117-A/1709: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497001 - JP 2011518117-A/2229: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982864 - JP 2011188866-A/172: IRNA AGENTS TARGETING VEGF.
HZ401998 - JP 2015177801-A/1709: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402518 - JP 2015177801-A/2229: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420095 - JP 2014094020-A/172: IRNA AGENTS TARGETING VEGF.
LZ247266 - JP 2016135144-A/172: IRNA AGENTS TARGETING VEGF.
FW553537 - IRNA AGENTS TARGETING VEGF.
HI963243 - Sequence 173 from Patent EP1735009.
HV496482 - JP 2011518117-A/1710: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497002 - JP 2011518117-A/2230: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982865 - JP 2011188866-A/173: IRNA AGENTS TARGETING VEGF.
HZ401999 - JP 2015177801-A/1710: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402519 - JP 2015177801-A/2230: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420096 - JP 2014094020-A/173: IRNA AGENTS TARGETING VEGF.
LZ247267 - JP 2016135144-A/173: IRNA AGENTS TARGETING VEGF.
FW553538 - IRNA AGENTS TARGETING VEGF.
HI963244 - Sequence 174 from Patent EP1735009.
HV496483 - JP 2011518117-A/1711: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982866 - JP 2011188866-A/174: IRNA AGENTS TARGETING VEGF.
HZ402000 - JP 2015177801-A/1711: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420097 - JP 2014094020-A/174: IRNA AGENTS TARGETING VEGF.
LZ247268 - JP 2016135144-A/174: IRNA AGENTS TARGETING VEGF.
FW553539 - IRNA AGENTS TARGETING VEGF.
HI963245 - Sequence 175 from Patent EP1735009.
HV496484 - JP 2011518117-A/1712: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982867 - JP 2011188866-A/175: IRNA AGENTS TARGETING VEGF.
HZ402001 - JP 2015177801-A/1712: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420098 - JP 2014094020-A/175: IRNA AGENTS TARGETING VEGF.
LZ247269 - JP 2016135144-A/175: IRNA AGENTS TARGETING VEGF.
FW553540 - IRNA AGENTS TARGETING VEGF.
HI963246 - Sequence 176 from Patent EP1735009.
HV496485 - JP 2011518117-A/1713: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497003 - JP 2011518117-A/2231: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982868 - JP 2011188866-A/176: IRNA AGENTS TARGETING VEGF.
HZ402002 - JP 2015177801-A/1713: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402520 - JP 2015177801-A/2231: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420099 - JP 2014094020-A/176: IRNA AGENTS TARGETING VEGF.
LZ247270 - JP 2016135144-A/176: IRNA AGENTS TARGETING VEGF.
FW553541 - IRNA AGENTS TARGETING VEGF.
HI963247 - Sequence 177 from Patent EP1735009.
HV496486 - JP 2011518117-A/1714: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982869 - JP 2011188866-A/177: IRNA AGENTS TARGETING VEGF.
HZ402003 - JP 2015177801-A/1714: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420100 - JP 2014094020-A/177: IRNA AGENTS TARGETING VEGF.
LZ247271 - JP 2016135144-A/177: IRNA AGENTS TARGETING VEGF.
FW553542 - IRNA AGENTS TARGETING VEGF.
HI963248 - Sequence 178 from Patent EP1735009.
HV496487 - JP 2011518117-A/1715: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982870 - JP 2011188866-A/178: IRNA AGENTS TARGETING VEGF.
HZ402004 - JP 2015177801-A/1715: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420101 - JP 2014094020-A/178: IRNA AGENTS TARGETING VEGF.
LZ247272 - JP 2016135144-A/178: IRNA AGENTS TARGETING VEGF.
FW553543 - IRNA AGENTS TARGETING VEGF.
HI963249 - Sequence 179 from Patent EP1735009.
HV496488 - JP 2011518117-A/1716: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982871 - JP 2011188866-A/179: IRNA AGENTS TARGETING VEGF.
HZ402005 - JP 2015177801-A/1716: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420102 - JP 2014094020-A/179: IRNA AGENTS TARGETING VEGF.
LZ247273 - JP 2016135144-A/179: IRNA AGENTS TARGETING VEGF.
FW553544 - IRNA AGENTS TARGETING VEGF.
HI963250 - Sequence 180 from Patent EP1735009.
HV496489 - JP 2011518117-A/1717: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497004 - JP 2011518117-A/2232: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982872 - JP 2011188866-A/180: IRNA AGENTS TARGETING VEGF.
HZ402006 - JP 2015177801-A/1717: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402521 - JP 2015177801-A/2232: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420103 - JP 2014094020-A/180: IRNA AGENTS TARGETING VEGF.
LZ247274 - JP 2016135144-A/180: IRNA AGENTS TARGETING VEGF.
FW553545 - IRNA AGENTS TARGETING VEGF.
HI963251 - Sequence 181 from Patent EP1735009.
HV496490 - JP 2011518117-A/1718: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982873 - JP 2011188866-A/181: IRNA AGENTS TARGETING VEGF.
HZ402007 - JP 2015177801-A/1718: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420104 - JP 2014094020-A/181: IRNA AGENTS TARGETING VEGF.
LZ247275 - JP 2016135144-A/181: IRNA AGENTS TARGETING VEGF.
FW553546 - IRNA AGENTS TARGETING VEGF.
HI963252 - Sequence 182 from Patent EP1735009.
HV496491 - JP 2011518117-A/1719: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982874 - JP 2011188866-A/182: IRNA AGENTS TARGETING VEGF.
HZ402008 - JP 2015177801-A/1719: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420105 - JP 2014094020-A/182: IRNA AGENTS TARGETING VEGF.
LZ247276 - JP 2016135144-A/182: IRNA AGENTS TARGETING VEGF.
FW553547 - IRNA AGENTS TARGETING VEGF.
HI963253 - Sequence 183 from Patent EP1735009.
HV496492 - JP 2011518117-A/1720: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982875 - JP 2011188866-A/183: IRNA AGENTS TARGETING VEGF.
HZ402009 - JP 2015177801-A/1720: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420106 - JP 2014094020-A/183: IRNA AGENTS TARGETING VEGF.
LZ247277 - JP 2016135144-A/183: IRNA AGENTS TARGETING VEGF.
FW553548 - IRNA AGENTS TARGETING VEGF.
HI963254 - Sequence 184 from Patent EP1735009.
HV496493 - JP 2011518117-A/1721: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982876 - JP 2011188866-A/184: IRNA AGENTS TARGETING VEGF.
HZ402010 - JP 2015177801-A/1721: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420107 - JP 2014094020-A/184: IRNA AGENTS TARGETING VEGF.
LZ247278 - JP 2016135144-A/184: IRNA AGENTS TARGETING VEGF.
FW553549 - IRNA AGENTS TARGETING VEGF.
HI963255 - Sequence 185 from Patent EP1735009.
HV496494 - JP 2011518117-A/1722: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982877 - JP 2011188866-A/185: IRNA AGENTS TARGETING VEGF.
HZ402011 - JP 2015177801-A/1722: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420108 - JP 2014094020-A/185: IRNA AGENTS TARGETING VEGF.
LZ247279 - JP 2016135144-A/185: IRNA AGENTS TARGETING VEGF.
FW553550 - IRNA AGENTS TARGETING VEGF.
HI963256 - Sequence 186 from Patent EP1735009.
HV496495 - JP 2011518117-A/1723: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982878 - JP 2011188866-A/186: IRNA AGENTS TARGETING VEGF.
HZ402012 - JP 2015177801-A/1723: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420109 - JP 2014094020-A/186: IRNA AGENTS TARGETING VEGF.
LZ247280 - JP 2016135144-A/186: IRNA AGENTS TARGETING VEGF.
FW553551 - IRNA AGENTS TARGETING VEGF.
HI963257 - Sequence 187 from Patent EP1735009.
HV496496 - JP 2011518117-A/1724: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982879 - JP 2011188866-A/187: IRNA AGENTS TARGETING VEGF.
HZ402013 - JP 2015177801-A/1724: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420110 - JP 2014094020-A/187: IRNA AGENTS TARGETING VEGF.
LZ247281 - JP 2016135144-A/187: IRNA AGENTS TARGETING VEGF.
FW553552 - IRNA AGENTS TARGETING VEGF.
HI963258 - Sequence 188 from Patent EP1735009.
HV496497 - JP 2011518117-A/1725: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982880 - JP 2011188866-A/188: IRNA AGENTS TARGETING VEGF.
HZ402014 - JP 2015177801-A/1725: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420111 - JP 2014094020-A/188: IRNA AGENTS TARGETING VEGF.
LZ247282 - JP 2016135144-A/188: IRNA AGENTS TARGETING VEGF.
FW553553 - IRNA AGENTS TARGETING VEGF.
HI963259 - Sequence 189 from Patent EP1735009.
HV496498 - JP 2011518117-A/1726: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982881 - JP 2011188866-A/189: IRNA AGENTS TARGETING VEGF.
HZ402015 - JP 2015177801-A/1726: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420112 - JP 2014094020-A/189: IRNA AGENTS TARGETING VEGF.
LZ247283 - JP 2016135144-A/189: IRNA AGENTS TARGETING VEGF.
FW553554 - IRNA AGENTS TARGETING VEGF.
HI963260 - Sequence 190 from Patent EP1735009.
HV496499 - JP 2011518117-A/1727: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982882 - JP 2011188866-A/190: IRNA AGENTS TARGETING VEGF.
HZ402016 - JP 2015177801-A/1727: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420113 - JP 2014094020-A/190: IRNA AGENTS TARGETING VEGF.
LZ247284 - JP 2016135144-A/190: IRNA AGENTS TARGETING VEGF.
FW553555 - IRNA AGENTS TARGETING VEGF.
HI963261 - Sequence 191 from Patent EP1735009.
HV496500 - JP 2011518117-A/1728: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982883 - JP 2011188866-A/191: IRNA AGENTS TARGETING VEGF.
HZ402017 - JP 2015177801-A/1728: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420114 - JP 2014094020-A/191: IRNA AGENTS TARGETING VEGF.
LZ247285 - JP 2016135144-A/191: IRNA AGENTS TARGETING VEGF.
FW553556 - IRNA AGENTS TARGETING VEGF.
HI963262 - Sequence 192 from Patent EP1735009.
HV496501 - JP 2011518117-A/1729: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497005 - JP 2011518117-A/2233: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982884 - JP 2011188866-A/192: IRNA AGENTS TARGETING VEGF.
HZ402018 - JP 2015177801-A/1729: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402522 - JP 2015177801-A/2233: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420115 - JP 2014094020-A/192: IRNA AGENTS TARGETING VEGF.
LZ247286 - JP 2016135144-A/192: IRNA AGENTS TARGETING VEGF.
FW553557 - IRNA AGENTS TARGETING VEGF.
HI963263 - Sequence 193 from Patent EP1735009.
HV496502 - JP 2011518117-A/1730: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497006 - JP 2011518117-A/2234: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982885 - JP 2011188866-A/193: IRNA AGENTS TARGETING VEGF.
HZ402019 - JP 2015177801-A/1730: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402523 - JP 2015177801-A/2234: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420116 - JP 2014094020-A/193: IRNA AGENTS TARGETING VEGF.
LZ247287 - JP 2016135144-A/193: IRNA AGENTS TARGETING VEGF.
FW553558 - IRNA AGENTS TARGETING VEGF.
HI963264 - Sequence 194 from Patent EP1735009.
HV496503 - JP 2011518117-A/1731: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982886 - JP 2011188866-A/194: IRNA AGENTS TARGETING VEGF.
HZ402020 - JP 2015177801-A/1731: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420117 - JP 2014094020-A/194: IRNA AGENTS TARGETING VEGF.
LZ247288 - JP 2016135144-A/194: IRNA AGENTS TARGETING VEGF.
FW553559 - IRNA AGENTS TARGETING VEGF.
HI963265 - Sequence 195 from Patent EP1735009.
HV496504 - JP 2011518117-A/1732: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982887 - JP 2011188866-A/195: IRNA AGENTS TARGETING VEGF.
HZ402021 - JP 2015177801-A/1732: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420118 - JP 2014094020-A/195: IRNA AGENTS TARGETING VEGF.
LZ247289 - JP 2016135144-A/195: IRNA AGENTS TARGETING VEGF.
FW553560 - IRNA AGENTS TARGETING VEGF.
HI963266 - Sequence 196 from Patent EP1735009.
HV496505 - JP 2011518117-A/1733: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982888 - JP 2011188866-A/196: IRNA AGENTS TARGETING VEGF.
HZ402022 - JP 2015177801-A/1733: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420119 - JP 2014094020-A/196: IRNA AGENTS TARGETING VEGF.
LZ247290 - JP 2016135144-A/196: IRNA AGENTS TARGETING VEGF.
FW553561 - IRNA AGENTS TARGETING VEGF.
HI963267 - Sequence 197 from Patent EP1735009.
HV496506 - JP 2011518117-A/1734: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982889 - JP 2011188866-A/197: IRNA AGENTS TARGETING VEGF.
HZ402023 - JP 2015177801-A/1734: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420120 - JP 2014094020-A/197: IRNA AGENTS TARGETING VEGF.
LZ247291 - JP 2016135144-A/197: IRNA AGENTS TARGETING VEGF.
FW553562 - IRNA AGENTS TARGETING VEGF.
HI963268 - Sequence 198 from Patent EP1735009.
HV496507 - JP 2011518117-A/1735: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982890 - JP 2011188866-A/198: IRNA AGENTS TARGETING VEGF.
HZ402024 - JP 2015177801-A/1735: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420121 - JP 2014094020-A/198: IRNA AGENTS TARGETING VEGF.
LZ247292 - JP 2016135144-A/198: IRNA AGENTS TARGETING VEGF.
FW553563 - IRNA AGENTS TARGETING VEGF.
HI963269 - Sequence 199 from Patent EP1735009.
HV496508 - JP 2011518117-A/1736: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982891 - JP 2011188866-A/199: IRNA AGENTS TARGETING VEGF.
HZ402025 - JP 2015177801-A/1736: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420122 - JP 2014094020-A/199: IRNA AGENTS TARGETING VEGF.
LZ247293 - JP 2016135144-A/199: IRNA AGENTS TARGETING VEGF.
FW553564 - IRNA AGENTS TARGETING VEGF.
HI963270 - Sequence 200 from Patent EP1735009.
HV496509 - JP 2011518117-A/1737: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982892 - JP 2011188866-A/200: IRNA AGENTS TARGETING VEGF.
HZ402026 - JP 2015177801-A/1737: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420123 - JP 2014094020-A/200: IRNA AGENTS TARGETING VEGF.
LZ247294 - JP 2016135144-A/200: IRNA AGENTS TARGETING VEGF.
FW553565 - IRNA AGENTS TARGETING VEGF.
HI963271 - Sequence 201 from Patent EP1735009.
HV496510 - JP 2011518117-A/1738: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982893 - JP 2011188866-A/201: IRNA AGENTS TARGETING VEGF.
HZ402027 - JP 2015177801-A/1738: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420124 - JP 2014094020-A/201: IRNA AGENTS TARGETING VEGF.
LZ247295 - JP 2016135144-A/201: IRNA AGENTS TARGETING VEGF.
FW553566 - IRNA AGENTS TARGETING VEGF.
HI963272 - Sequence 202 from Patent EP1735009.
HV496511 - JP 2011518117-A/1739: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982894 - JP 2011188866-A/202: IRNA AGENTS TARGETING VEGF.
HZ402028 - JP 2015177801-A/1739: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420125 - JP 2014094020-A/202: IRNA AGENTS TARGETING VEGF.
LZ247296 - JP 2016135144-A/202: IRNA AGENTS TARGETING VEGF.
FW553567 - IRNA AGENTS TARGETING VEGF.
HI963273 - Sequence 203 from Patent EP1735009.
HV496512 - JP 2011518117-A/1740: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982895 - JP 2011188866-A/203: IRNA AGENTS TARGETING VEGF.
HZ402029 - JP 2015177801-A/1740: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420126 - JP 2014094020-A/203: IRNA AGENTS TARGETING VEGF.
LZ247297 - JP 2016135144-A/203: IRNA AGENTS TARGETING VEGF.
FW553568 - IRNA AGENTS TARGETING VEGF.
HI963274 - Sequence 204 from Patent EP1735009.
HV496513 - JP 2011518117-A/1741: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982896 - JP 2011188866-A/204: IRNA AGENTS TARGETING VEGF.
HZ402030 - JP 2015177801-A/1741: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420127 - JP 2014094020-A/204: IRNA AGENTS TARGETING VEGF.
LZ247298 - JP 2016135144-A/204: IRNA AGENTS TARGETING VEGF.
FW553569 - IRNA AGENTS TARGETING VEGF.
HI963275 - Sequence 205 from Patent EP1735009.
HV496514 - JP 2011518117-A/1742: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982897 - JP 2011188866-A/205: IRNA AGENTS TARGETING VEGF.
HZ402031 - JP 2015177801-A/1742: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420128 - JP 2014094020-A/205: IRNA AGENTS TARGETING VEGF.
LZ247299 - JP 2016135144-A/205: IRNA AGENTS TARGETING VEGF.
FW553570 - IRNA AGENTS TARGETING VEGF.
HI963276 - Sequence 206 from Patent EP1735009.
HV496515 - JP 2011518117-A/1743: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982898 - JP 2011188866-A/206: IRNA AGENTS TARGETING VEGF.
HZ402032 - JP 2015177801-A/1743: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420129 - JP 2014094020-A/206: IRNA AGENTS TARGETING VEGF.
LZ247300 - JP 2016135144-A/206: IRNA AGENTS TARGETING VEGF.
FW553571 - IRNA AGENTS TARGETING VEGF.
HI963277 - Sequence 207 from Patent EP1735009.
HV496516 - JP 2011518117-A/1744: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982899 - JP 2011188866-A/207: IRNA AGENTS TARGETING VEGF.
HZ402033 - JP 2015177801-A/1744: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420130 - JP 2014094020-A/207: IRNA AGENTS TARGETING VEGF.
LZ247301 - JP 2016135144-A/207: IRNA AGENTS TARGETING VEGF.
FW553572 - IRNA AGENTS TARGETING VEGF.
HI963278 - Sequence 208 from Patent EP1735009.
HV496517 - JP 2011518117-A/1745: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982900 - JP 2011188866-A/208: IRNA AGENTS TARGETING VEGF.
HZ402034 - JP 2015177801-A/1745: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420131 - JP 2014094020-A/208: IRNA AGENTS TARGETING VEGF.
LZ247302 - JP 2016135144-A/208: IRNA AGENTS TARGETING VEGF.
FW553573 - IRNA AGENTS TARGETING VEGF.
HI963279 - Sequence 209 from Patent EP1735009.
HV496518 - JP 2011518117-A/1746: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982901 - JP 2011188866-A/209: IRNA AGENTS TARGETING VEGF.
HZ402035 - JP 2015177801-A/1746: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420132 - JP 2014094020-A/209: IRNA AGENTS TARGETING VEGF.
LZ247303 - JP 2016135144-A/209: IRNA AGENTS TARGETING VEGF.
FW553574 - IRNA AGENTS TARGETING VEGF.
HI963280 - Sequence 210 from Patent EP1735009.
HV496519 - JP 2011518117-A/1747: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497007 - JP 2011518117-A/2235: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982902 - JP 2011188866-A/210: IRNA AGENTS TARGETING VEGF.
HZ402036 - JP 2015177801-A/1747: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402524 - JP 2015177801-A/2235: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420133 - JP 2014094020-A/210: IRNA AGENTS TARGETING VEGF.
LZ247304 - JP 2016135144-A/210: IRNA AGENTS TARGETING VEGF.
FW553577 - IRNA AGENTS TARGETING VEGF.
HI963283 - Sequence 213 from Patent EP1735009.
HV496522 - JP 2011518117-A/1750: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982905 - JP 2011188866-A/213: IRNA AGENTS TARGETING VEGF.
HZ402039 - JP 2015177801-A/1750: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420136 - JP 2014094020-A/213: IRNA AGENTS TARGETING VEGF.
LZ247307 - JP 2016135144-A/213: IRNA AGENTS TARGETING VEGF.
FW553578 - IRNA AGENTS TARGETING VEGF.
HI963284 - Sequence 214 from Patent EP1735009.
HV496523 - JP 2011518117-A/1751: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982906 - JP 2011188866-A/214: IRNA AGENTS TARGETING VEGF.
HZ402040 - JP 2015177801-A/1751: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420137 - JP 2014094020-A/214: IRNA AGENTS TARGETING VEGF.
LZ247308 - JP 2016135144-A/214: IRNA AGENTS TARGETING VEGF.
FW553579 - IRNA AGENTS TARGETING VEGF.
HI963285 - Sequence 215 from Patent EP1735009.
HV496524 - JP 2011518117-A/1752: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982907 - JP 2011188866-A/215: IRNA AGENTS TARGETING VEGF.
HZ402041 - JP 2015177801-A/1752: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420138 - JP 2014094020-A/215: IRNA AGENTS TARGETING VEGF.
LZ247309 - JP 2016135144-A/215: IRNA AGENTS TARGETING VEGF.
FW553582 - IRNA AGENTS TARGETING VEGF.
HI963288 - Sequence 218 from Patent EP1735009.
HV496527 - JP 2011518117-A/1755: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982910 - JP 2011188866-A/218: IRNA AGENTS TARGETING VEGF.
HZ402044 - JP 2015177801-A/1755: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420141 - JP 2014094020-A/218: IRNA AGENTS TARGETING VEGF.
LZ247312 - JP 2016135144-A/218: IRNA AGENTS TARGETING VEGF.
FW553583 - IRNA AGENTS TARGETING VEGF.
HI963289 - Sequence 219 from Patent EP1735009.
HV496528 - JP 2011518117-A/1756: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982911 - JP 2011188866-A/219: IRNA AGENTS TARGETING VEGF.
HZ402045 - JP 2015177801-A/1756: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420142 - JP 2014094020-A/219: IRNA AGENTS TARGETING VEGF.
LZ247313 - JP 2016135144-A/219: IRNA AGENTS TARGETING VEGF.
FW553584 - IRNA AGENTS TARGETING VEGF.
HI963290 - Sequence 220 from Patent EP1735009.
HV496529 - JP 2011518117-A/1757: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982912 - JP 2011188866-A/220: IRNA AGENTS TARGETING VEGF.
HZ402046 - JP 2015177801-A/1757: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420143 - JP 2014094020-A/220: IRNA AGENTS TARGETING VEGF.
LZ247314 - JP 2016135144-A/220: IRNA AGENTS TARGETING VEGF.
FW553585 - IRNA AGENTS TARGETING VEGF.
HI963291 - Sequence 221 from Patent EP1735009.
HV496530 - JP 2011518117-A/1758: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982913 - JP 2011188866-A/221: IRNA AGENTS TARGETING VEGF.
HZ402047 - JP 2015177801-A/1758: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420144 - JP 2014094020-A/221: IRNA AGENTS TARGETING VEGF.
LZ247315 - JP 2016135144-A/221: IRNA AGENTS TARGETING VEGF.
FW553586 - IRNA AGENTS TARGETING VEGF.
HI963292 - Sequence 222 from Patent EP1735009.
HV496531 - JP 2011518117-A/1759: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982914 - JP 2011188866-A/222: IRNA AGENTS TARGETING VEGF.
HZ402048 - JP 2015177801-A/1759: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420145 - JP 2014094020-A/222: IRNA AGENTS TARGETING VEGF.
LZ247316 - JP 2016135144-A/222: IRNA AGENTS TARGETING VEGF.
FW553587 - IRNA AGENTS TARGETING VEGF.
HI963293 - Sequence 223 from Patent EP1735009.
HV496532 - JP 2011518117-A/1760: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982915 - JP 2011188866-A/223: IRNA AGENTS TARGETING VEGF.
HZ402049 - JP 2015177801-A/1760: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420146 - JP 2014094020-A/223: IRNA AGENTS TARGETING VEGF.
LZ247317 - JP 2016135144-A/223: IRNA AGENTS TARGETING VEGF.
FW553588 - IRNA AGENTS TARGETING VEGF.
HI963294 - Sequence 224 from Patent EP1735009.
HV496533 - JP 2011518117-A/1761: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982916 - JP 2011188866-A/224: IRNA AGENTS TARGETING VEGF.
HZ402050 - JP 2015177801-A/1761: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420147 - JP 2014094020-A/224: IRNA AGENTS TARGETING VEGF.
LZ247318 - JP 2016135144-A/224: IRNA AGENTS TARGETING VEGF.
FW553589 - IRNA AGENTS TARGETING VEGF.
HI963295 - Sequence 225 from Patent EP1735009.
HV496534 - JP 2011518117-A/1762: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982917 - JP 2011188866-A/225: IRNA AGENTS TARGETING VEGF.
HZ402051 - JP 2015177801-A/1762: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420148 - JP 2014094020-A/225: IRNA AGENTS TARGETING VEGF.
LZ247319 - JP 2016135144-A/225: IRNA AGENTS TARGETING VEGF.
FW553590 - IRNA AGENTS TARGETING VEGF.
HI963296 - Sequence 226 from Patent EP1735009.
HV496535 - JP 2011518117-A/1763: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982918 - JP 2011188866-A/226: IRNA AGENTS TARGETING VEGF.
HZ402052 - JP 2015177801-A/1763: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420149 - JP 2014094020-A/226: IRNA AGENTS TARGETING VEGF.
LZ247320 - JP 2016135144-A/226: IRNA AGENTS TARGETING VEGF.
FW553591 - IRNA AGENTS TARGETING VEGF.
HI963297 - Sequence 227 from Patent EP1735009.
HV496536 - JP 2011518117-A/1764: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982919 - JP 2011188866-A/227: IRNA AGENTS TARGETING VEGF.
HZ402053 - JP 2015177801-A/1764: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420150 - JP 2014094020-A/227: IRNA AGENTS TARGETING VEGF.
LZ247321 - JP 2016135144-A/227: IRNA AGENTS TARGETING VEGF.
FW553592 - IRNA AGENTS TARGETING VEGF.
HI963298 - Sequence 228 from Patent EP1735009.
HV496537 - JP 2011518117-A/1765: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982920 - JP 2011188866-A/228: IRNA AGENTS TARGETING VEGF.
HZ402054 - JP 2015177801-A/1765: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420151 - JP 2014094020-A/228: IRNA AGENTS TARGETING VEGF.
LZ247322 - JP 2016135144-A/228: IRNA AGENTS TARGETING VEGF.
FW553593 - IRNA AGENTS TARGETING VEGF.
HI963299 - Sequence 229 from Patent EP1735009.
HV496538 - JP 2011518117-A/1766: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982921 - JP 2011188866-A/229: IRNA AGENTS TARGETING VEGF.
HZ402055 - JP 2015177801-A/1766: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420152 - JP 2014094020-A/229: IRNA AGENTS TARGETING VEGF.
LZ247323 - JP 2016135144-A/229: IRNA AGENTS TARGETING VEGF.
FW553594 - IRNA AGENTS TARGETING VEGF.
HI963300 - Sequence 230 from Patent EP1735009.
HV496539 - JP 2011518117-A/1767: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982922 - JP 2011188866-A/230: IRNA AGENTS TARGETING VEGF.
HZ402056 - JP 2015177801-A/1767: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420153 - JP 2014094020-A/230: IRNA AGENTS TARGETING VEGF.
LZ247324 - JP 2016135144-A/230: IRNA AGENTS TARGETING VEGF.
FW553595 - IRNA AGENTS TARGETING VEGF.
HI963301 - Sequence 231 from Patent EP1735009.
HV496540 - JP 2011518117-A/1768: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982923 - JP 2011188866-A/231: IRNA AGENTS TARGETING VEGF.
HZ402057 - JP 2015177801-A/1768: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420154 - JP 2014094020-A/231: IRNA AGENTS TARGETING VEGF.
LZ247325 - JP 2016135144-A/231: IRNA AGENTS TARGETING VEGF.
FW553596 - IRNA AGENTS TARGETING VEGF.
HI963302 - Sequence 232 from Patent EP1735009.
HV496541 - JP 2011518117-A/1769: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982924 - JP 2011188866-A/232: IRNA AGENTS TARGETING VEGF.
HZ402058 - JP 2015177801-A/1769: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420155 - JP 2014094020-A/232: IRNA AGENTS TARGETING VEGF.
LZ247326 - JP 2016135144-A/232: IRNA AGENTS TARGETING VEGF.
FW553597 - IRNA AGENTS TARGETING VEGF.
HI963303 - Sequence 233 from Patent EP1735009.
HV496542 - JP 2011518117-A/1770: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982925 - JP 2011188866-A/233: IRNA AGENTS TARGETING VEGF.
HZ402059 - JP 2015177801-A/1770: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420156 - JP 2014094020-A/233: IRNA AGENTS TARGETING VEGF.
LZ247327 - JP 2016135144-A/233: IRNA AGENTS TARGETING VEGF.
FW553598 - IRNA AGENTS TARGETING VEGF.
HI963304 - Sequence 234 from Patent EP1735009.
HV496543 - JP 2011518117-A/1771: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982926 - JP 2011188866-A/234: IRNA AGENTS TARGETING VEGF.
HZ402060 - JP 2015177801-A/1771: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420157 - JP 2014094020-A/234: IRNA AGENTS TARGETING VEGF.
LZ247328 - JP 2016135144-A/234: IRNA AGENTS TARGETING VEGF.
FW553599 - IRNA AGENTS TARGETING VEGF.
HI963305 - Sequence 235 from Patent EP1735009.
HV496544 - JP 2011518117-A/1772: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982927 - JP 2011188866-A/235: IRNA AGENTS TARGETING VEGF.
HZ402061 - JP 2015177801-A/1772: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420158 - JP 2014094020-A/235: IRNA AGENTS TARGETING VEGF.
LZ247329 - JP 2016135144-A/235: IRNA AGENTS TARGETING VEGF.
FW553600 - IRNA AGENTS TARGETING VEGF.
HI963306 - Sequence 236 from Patent EP1735009.
HV496545 - JP 2011518117-A/1773: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982928 - JP 2011188866-A/236: IRNA AGENTS TARGETING VEGF.
HZ402062 - JP 2015177801-A/1773: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420159 - JP 2014094020-A/236: IRNA AGENTS TARGETING VEGF.
LZ247330 - JP 2016135144-A/236: IRNA AGENTS TARGETING VEGF.
FW553601 - IRNA AGENTS TARGETING VEGF.
HI963307 - Sequence 237 from Patent EP1735009.
HV496546 - JP 2011518117-A/1774: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982929 - JP 2011188866-A/237: IRNA AGENTS TARGETING VEGF.
HZ402063 - JP 2015177801-A/1774: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420160 - JP 2014094020-A/237: IRNA AGENTS TARGETING VEGF.
LZ247331 - JP 2016135144-A/237: IRNA AGENTS TARGETING VEGF.
FW553602 - IRNA AGENTS TARGETING VEGF.
HI963308 - Sequence 238 from Patent EP1735009.
HV496547 - JP 2011518117-A/1775: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982930 - JP 2011188866-A/238: IRNA AGENTS TARGETING VEGF.
HZ402064 - JP 2015177801-A/1775: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420161 - JP 2014094020-A/238: IRNA AGENTS TARGETING VEGF.
LZ247332 - JP 2016135144-A/238: IRNA AGENTS TARGETING VEGF.
FW553603 - IRNA AGENTS TARGETING VEGF.
HI963309 - Sequence 239 from Patent EP1735009.
HV496548 - JP 2011518117-A/1776: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982931 - JP 2011188866-A/239: IRNA AGENTS TARGETING VEGF.
HZ402065 - JP 2015177801-A/1776: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420162 - JP 2014094020-A/239: IRNA AGENTS TARGETING VEGF.
LZ247333 - JP 2016135144-A/239: IRNA AGENTS TARGETING VEGF.
FW553604 - IRNA AGENTS TARGETING VEGF.
HI963310 - Sequence 240 from Patent EP1735009.
HV496549 - JP 2011518117-A/1777: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982932 - JP 2011188866-A/240: IRNA AGENTS TARGETING VEGF.
HZ402066 - JP 2015177801-A/1777: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420163 - JP 2014094020-A/240: IRNA AGENTS TARGETING VEGF.
LZ247334 - JP 2016135144-A/240: IRNA AGENTS TARGETING VEGF.
FW553605 - IRNA AGENTS TARGETING VEGF.
HI963311 - Sequence 241 from Patent EP1735009.
HV496550 - JP 2011518117-A/1778: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982933 - JP 2011188866-A/241: IRNA AGENTS TARGETING VEGF.
HZ402067 - JP 2015177801-A/1778: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420164 - JP 2014094020-A/241: IRNA AGENTS TARGETING VEGF.
LZ247335 - JP 2016135144-A/241: IRNA AGENTS TARGETING VEGF.
FW553606 - IRNA AGENTS TARGETING VEGF.
HI963312 - Sequence 242 from Patent EP1735009.
HV496551 - JP 2011518117-A/1779: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982934 - JP 2011188866-A/242: IRNA AGENTS TARGETING VEGF.
HZ402068 - JP 2015177801-A/1779: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420165 - JP 2014094020-A/242: IRNA AGENTS TARGETING VEGF.
LZ247336 - JP 2016135144-A/242: IRNA AGENTS TARGETING VEGF.
FW553607 - IRNA AGENTS TARGETING VEGF.
HI963313 - Sequence 243 from Patent EP1735009.
HV496552 - JP 2011518117-A/1780: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982935 - JP 2011188866-A/243: IRNA AGENTS TARGETING VEGF.
HZ402069 - JP 2015177801-A/1780: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420166 - JP 2014094020-A/243: IRNA AGENTS TARGETING VEGF.
LZ247337 - JP 2016135144-A/243: IRNA AGENTS TARGETING VEGF.
FW553608 - IRNA AGENTS TARGETING VEGF.
HI963314 - Sequence 244 from Patent EP1735009.
HV496553 - JP 2011518117-A/1781: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982936 - JP 2011188866-A/244: IRNA AGENTS TARGETING VEGF.
HZ402070 - JP 2015177801-A/1781: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420167 - JP 2014094020-A/244: IRNA AGENTS TARGETING VEGF.
LZ247338 - JP 2016135144-A/244: IRNA AGENTS TARGETING VEGF.
FW553609 - IRNA AGENTS TARGETING VEGF.
HI963315 - Sequence 245 from Patent EP1735009.
HV496554 - JP 2011518117-A/1782: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982937 - JP 2011188866-A/245: IRNA AGENTS TARGETING VEGF.
HZ402071 - JP 2015177801-A/1782: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420168 - JP 2014094020-A/245: IRNA AGENTS TARGETING VEGF.
LZ247339 - JP 2016135144-A/245: IRNA AGENTS TARGETING VEGF.
FW553610 - IRNA AGENTS TARGETING VEGF.
HI963316 - Sequence 246 from Patent EP1735009.
HV496555 - JP 2011518117-A/1783: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982938 - JP 2011188866-A/246: IRNA AGENTS TARGETING VEGF.
HZ402072 - JP 2015177801-A/1783: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420169 - JP 2014094020-A/246: IRNA AGENTS TARGETING VEGF.
LZ247340 - JP 2016135144-A/246: IRNA AGENTS TARGETING VEGF.
FW553611 - IRNA AGENTS TARGETING VEGF.
HI963317 - Sequence 247 from Patent EP1735009.
HV496556 - JP 2011518117-A/1784: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982939 - JP 2011188866-A/247: IRNA AGENTS TARGETING VEGF.
HZ402073 - JP 2015177801-A/1784: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420170 - JP 2014094020-A/247: IRNA AGENTS TARGETING VEGF.
LZ247341 - JP 2016135144-A/247: IRNA AGENTS TARGETING VEGF.
FW553612 - IRNA AGENTS TARGETING VEGF.
HI963318 - Sequence 248 from Patent EP1735009.
HV496557 - JP 2011518117-A/1785: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982940 - JP 2011188866-A/248: IRNA AGENTS TARGETING VEGF.
HZ402074 - JP 2015177801-A/1785: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420171 - JP 2014094020-A/248: IRNA AGENTS TARGETING VEGF.
LZ247342 - JP 2016135144-A/248: IRNA AGENTS TARGETING VEGF.
FW553613 - IRNA AGENTS TARGETING VEGF.
HI963319 - Sequence 249 from Patent EP1735009.
HV496558 - JP 2011518117-A/1786: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982941 - JP 2011188866-A/249: IRNA AGENTS TARGETING VEGF.
HZ402075 - JP 2015177801-A/1786: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420172 - JP 2014094020-A/249: IRNA AGENTS TARGETING VEGF.
LZ247343 - JP 2016135144-A/249: IRNA AGENTS TARGETING VEGF.
FW553614 - IRNA AGENTS TARGETING VEGF.
HI963320 - Sequence 250 from Patent EP1735009.
HV496559 - JP 2011518117-A/1787: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982942 - JP 2011188866-A/250: IRNA AGENTS TARGETING VEGF.
HZ402076 - JP 2015177801-A/1787: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420173 - JP 2014094020-A/250: IRNA AGENTS TARGETING VEGF.
LZ247344 - JP 2016135144-A/250: IRNA AGENTS TARGETING VEGF.
FW553615 - IRNA AGENTS TARGETING VEGF.
HI963321 - Sequence 251 from Patent EP1735009.
HV496560 - JP 2011518117-A/1788: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982943 - JP 2011188866-A/251: IRNA AGENTS TARGETING VEGF.
HZ402077 - JP 2015177801-A/1788: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420174 - JP 2014094020-A/251: IRNA AGENTS TARGETING VEGF.
LZ247345 - JP 2016135144-A/251: IRNA AGENTS TARGETING VEGF.
FW553616 - IRNA AGENTS TARGETING VEGF.
HI963322 - Sequence 252 from Patent EP1735009.
HV496561 - JP 2011518117-A/1789: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982944 - JP 2011188866-A/252: IRNA AGENTS TARGETING VEGF.
HZ402078 - JP 2015177801-A/1789: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420175 - JP 2014094020-A/252: IRNA AGENTS TARGETING VEGF.
LZ247346 - JP 2016135144-A/252: IRNA AGENTS TARGETING VEGF.
FW553617 - IRNA AGENTS TARGETING VEGF.
HI963323 - Sequence 253 from Patent EP1735009.
HV496562 - JP 2011518117-A/1790: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982945 - JP 2011188866-A/253: IRNA AGENTS TARGETING VEGF.
HZ402079 - JP 2015177801-A/1790: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420176 - JP 2014094020-A/253: IRNA AGENTS TARGETING VEGF.
LZ247347 - JP 2016135144-A/253: IRNA AGENTS TARGETING VEGF.
FW553618 - IRNA AGENTS TARGETING VEGF.
HI963324 - Sequence 254 from Patent EP1735009.
HV496563 - JP 2011518117-A/1791: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982946 - JP 2011188866-A/254: IRNA AGENTS TARGETING VEGF.
HZ402080 - JP 2015177801-A/1791: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420177 - JP 2014094020-A/254: IRNA AGENTS TARGETING VEGF.
LZ247348 - JP 2016135144-A/254: IRNA AGENTS TARGETING VEGF.
FW553619 - IRNA AGENTS TARGETING VEGF.
HI963325 - Sequence 255 from Patent EP1735009.
HV496564 - JP 2011518117-A/1792: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982947 - JP 2011188866-A/255: IRNA AGENTS TARGETING VEGF.
HZ402081 - JP 2015177801-A/1792: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420178 - JP 2014094020-A/255: IRNA AGENTS TARGETING VEGF.
LZ247349 - JP 2016135144-A/255: IRNA AGENTS TARGETING VEGF.
FW553620 - IRNA AGENTS TARGETING VEGF.
HI963326 - Sequence 256 from Patent EP1735009.
HV496565 - JP 2011518117-A/1793: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982948 - JP 2011188866-A/256: IRNA AGENTS TARGETING VEGF.
HZ402082 - JP 2015177801-A/1793: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420179 - JP 2014094020-A/256: IRNA AGENTS TARGETING VEGF.
LZ247350 - JP 2016135144-A/256: IRNA AGENTS TARGETING VEGF.
FW553621 - IRNA AGENTS TARGETING VEGF.
HI963327 - Sequence 257 from Patent EP1735009.
HV496566 - JP 2011518117-A/1794: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982949 - JP 2011188866-A/257: IRNA AGENTS TARGETING VEGF.
HZ402083 - JP 2015177801-A/1794: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420180 - JP 2014094020-A/257: IRNA AGENTS TARGETING VEGF.
LZ247351 - JP 2016135144-A/257: IRNA AGENTS TARGETING VEGF.
FW553622 - IRNA AGENTS TARGETING VEGF.
HI963328 - Sequence 258 from Patent EP1735009.
HV496567 - JP 2011518117-A/1795: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982950 - JP 2011188866-A/258: IRNA AGENTS TARGETING VEGF.
HZ402084 - JP 2015177801-A/1795: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420181 - JP 2014094020-A/258: IRNA AGENTS TARGETING VEGF.
LZ247352 - JP 2016135144-A/258: IRNA AGENTS TARGETING VEGF.
FW553623 - IRNA AGENTS TARGETING VEGF.
HI963329 - Sequence 259 from Patent EP1735009.
HV496568 - JP 2011518117-A/1796: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982951 - JP 2011188866-A/259: IRNA AGENTS TARGETING VEGF.
HZ402085 - JP 2015177801-A/1796: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420182 - JP 2014094020-A/259: IRNA AGENTS TARGETING VEGF.
LZ247353 - JP 2016135144-A/259: IRNA AGENTS TARGETING VEGF.
FW553624 - IRNA AGENTS TARGETING VEGF.
HI963330 - Sequence 260 from Patent EP1735009.
HV496569 - JP 2011518117-A/1797: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982952 - JP 2011188866-A/260: IRNA AGENTS TARGETING VEGF.
HZ402086 - JP 2015177801-A/1797: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420183 - JP 2014094020-A/260: IRNA AGENTS TARGETING VEGF.
LZ247354 - JP 2016135144-A/260: IRNA AGENTS TARGETING VEGF.
FW553625 - IRNA AGENTS TARGETING VEGF.
HI963331 - Sequence 261 from Patent EP1735009.
HV496570 - JP 2011518117-A/1798: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497008 - JP 2011518117-A/2236: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982953 - JP 2011188866-A/261: IRNA AGENTS TARGETING VEGF.
HZ402087 - JP 2015177801-A/1798: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402525 - JP 2015177801-A/2236: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420184 - JP 2014094020-A/261: IRNA AGENTS TARGETING VEGF.
LZ247355 - JP 2016135144-A/261: IRNA AGENTS TARGETING VEGF.
FW553626 - IRNA AGENTS TARGETING VEGF.
HI963332 - Sequence 262 from Patent EP1735009.
HV496571 - JP 2011518117-A/1799: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982954 - JP 2011188866-A/262: IRNA AGENTS TARGETING VEGF.
HZ402088 - JP 2015177801-A/1799: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420185 - JP 2014094020-A/262: IRNA AGENTS TARGETING VEGF.
LZ247356 - JP 2016135144-A/262: IRNA AGENTS TARGETING VEGF.
FW553627 - IRNA AGENTS TARGETING VEGF.
HI963333 - Sequence 263 from Patent EP1735009.
HV496572 - JP 2011518117-A/1800: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982955 - JP 2011188866-A/263: IRNA AGENTS TARGETING VEGF.
HZ402089 - JP 2015177801-A/1800: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420186 - JP 2014094020-A/263: IRNA AGENTS TARGETING VEGF.
LZ247357 - JP 2016135144-A/263: IRNA AGENTS TARGETING VEGF.
FW553628 - IRNA AGENTS TARGETING VEGF.
HI963334 - Sequence 264 from Patent EP1735009.
HV496573 - JP 2011518117-A/1801: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497009 - JP 2011518117-A/2237: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982956 - JP 2011188866-A/264: IRNA AGENTS TARGETING VEGF.
HZ402090 - JP 2015177801-A/1801: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402526 - JP 2015177801-A/2237: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420187 - JP 2014094020-A/264: IRNA AGENTS TARGETING VEGF.
LZ247358 - JP 2016135144-A/264: IRNA AGENTS TARGETING VEGF.
FW553629 - IRNA AGENTS TARGETING VEGF.
HI963335 - Sequence 265 from Patent EP1735009.
HV496574 - JP 2011518117-A/1802: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982957 - JP 2011188866-A/265: IRNA AGENTS TARGETING VEGF.
HZ402091 - JP 2015177801-A/1802: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420188 - JP 2014094020-A/265: IRNA AGENTS TARGETING VEGF.
LZ247359 - JP 2016135144-A/265: IRNA AGENTS TARGETING VEGF.
FW553630 - IRNA AGENTS TARGETING VEGF.
HI963336 - Sequence 266 from Patent EP1735009.
HV496575 - JP 2011518117-A/1803: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982958 - JP 2011188866-A/266: IRNA AGENTS TARGETING VEGF.
HZ402092 - JP 2015177801-A/1803: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420189 - JP 2014094020-A/266: IRNA AGENTS TARGETING VEGF.
LZ247360 - JP 2016135144-A/266: IRNA AGENTS TARGETING VEGF.
FW553631 - IRNA AGENTS TARGETING VEGF.
HI963337 - Sequence 267 from Patent EP1735009.
HV496576 - JP 2011518117-A/1804: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982959 - JP 2011188866-A/267: IRNA AGENTS TARGETING VEGF.
HZ402093 - JP 2015177801-A/1804: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420190 - JP 2014094020-A/267: IRNA AGENTS TARGETING VEGF.
LZ247361 - JP 2016135144-A/267: IRNA AGENTS TARGETING VEGF.
FW553632 - IRNA AGENTS TARGETING VEGF.
HI963338 - Sequence 268 from Patent EP1735009.
HV496577 - JP 2011518117-A/1805: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982960 - JP 2011188866-A/268: IRNA AGENTS TARGETING VEGF.
HZ402094 - JP 2015177801-A/1805: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420191 - JP 2014094020-A/268: IRNA AGENTS TARGETING VEGF.
LZ247362 - JP 2016135144-A/268: IRNA AGENTS TARGETING VEGF.
FW553633 - IRNA AGENTS TARGETING VEGF.
HI963339 - Sequence 269 from Patent EP1735009.
HV496578 - JP 2011518117-A/1806: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982961 - JP 2011188866-A/269: IRNA AGENTS TARGETING VEGF.
HZ402095 - JP 2015177801-A/1806: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420192 - JP 2014094020-A/269: IRNA AGENTS TARGETING VEGF.
LZ247363 - JP 2016135144-A/269: IRNA AGENTS TARGETING VEGF.
FW553634 - IRNA AGENTS TARGETING VEGF.
HI963340 - Sequence 270 from Patent EP1735009.
HV496579 - JP 2011518117-A/1807: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982962 - JP 2011188866-A/270: IRNA AGENTS TARGETING VEGF.
HZ402096 - JP 2015177801-A/1807: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420193 - JP 2014094020-A/270: IRNA AGENTS TARGETING VEGF.
LZ247364 - JP 2016135144-A/270: IRNA AGENTS TARGETING VEGF.
FW553635 - IRNA AGENTS TARGETING VEGF.
HI963341 - Sequence 271 from Patent EP1735009.
HV496580 - JP 2011518117-A/1808: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982963 - JP 2011188866-A/271: IRNA AGENTS TARGETING VEGF.
HZ402097 - JP 2015177801-A/1808: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420194 - JP 2014094020-A/271: IRNA AGENTS TARGETING VEGF.
LZ247365 - JP 2016135144-A/271: IRNA AGENTS TARGETING VEGF.
FW553636 - IRNA AGENTS TARGETING VEGF.
HI963342 - Sequence 272 from Patent EP1735009.
HV496581 - JP 2011518117-A/1809: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982964 - JP 2011188866-A/272: IRNA AGENTS TARGETING VEGF.
HZ402098 - JP 2015177801-A/1809: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420195 - JP 2014094020-A/272: IRNA AGENTS TARGETING VEGF.
LZ247366 - JP 2016135144-A/272: IRNA AGENTS TARGETING VEGF.
FW553637 - IRNA AGENTS TARGETING VEGF.
HI963343 - Sequence 273 from Patent EP1735009.
HV496582 - JP 2011518117-A/1810: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982965 - JP 2011188866-A/273: IRNA AGENTS TARGETING VEGF.
HZ402099 - JP 2015177801-A/1810: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420196 - JP 2014094020-A/273: IRNA AGENTS TARGETING VEGF.
LZ247367 - JP 2016135144-A/273: IRNA AGENTS TARGETING VEGF.
FW553638 - IRNA AGENTS TARGETING VEGF.
HI963344 - Sequence 274 from Patent EP1735009.
HV496583 - JP 2011518117-A/1811: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982966 - JP 2011188866-A/274: IRNA AGENTS TARGETING VEGF.
HZ402100 - JP 2015177801-A/1811: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420197 - JP 2014094020-A/274: IRNA AGENTS TARGETING VEGF.
LZ247368 - JP 2016135144-A/274: IRNA AGENTS TARGETING VEGF.
FW553639 - IRNA AGENTS TARGETING VEGF.
HI963345 - Sequence 275 from Patent EP1735009.
HV496584 - JP 2011518117-A/1812: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982967 - JP 2011188866-A/275: IRNA AGENTS TARGETING VEGF.
HZ402101 - JP 2015177801-A/1812: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420198 - JP 2014094020-A/275: IRNA AGENTS TARGETING VEGF.
LZ247369 - JP 2016135144-A/275: IRNA AGENTS TARGETING VEGF.
FW553640 - IRNA AGENTS TARGETING VEGF.
HI963346 - Sequence 276 from Patent EP1735009.
HV496585 - JP 2011518117-A/1813: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982968 - JP 2011188866-A/276: IRNA AGENTS TARGETING VEGF.
HZ402102 - JP 2015177801-A/1813: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420199 - JP 2014094020-A/276: IRNA AGENTS TARGETING VEGF.
LZ247370 - JP 2016135144-A/276: IRNA AGENTS TARGETING VEGF.
FW553641 - IRNA AGENTS TARGETING VEGF.
HI963347 - Sequence 277 from Patent EP1735009.
HV496586 - JP 2011518117-A/1814: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982969 - JP 2011188866-A/277: IRNA AGENTS TARGETING VEGF.
HZ402103 - JP 2015177801-A/1814: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420200 - JP 2014094020-A/277: IRNA AGENTS TARGETING VEGF.
LZ247371 - JP 2016135144-A/277: IRNA AGENTS TARGETING VEGF.
FW553642 - IRNA AGENTS TARGETING VEGF.
HI963348 - Sequence 278 from Patent EP1735009.
HV496587 - JP 2011518117-A/1815: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982970 - JP 2011188866-A/278: IRNA AGENTS TARGETING VEGF.
HZ402104 - JP 2015177801-A/1815: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420201 - JP 2014094020-A/278: IRNA AGENTS TARGETING VEGF.
LZ247372 - JP 2016135144-A/278: IRNA AGENTS TARGETING VEGF.
FW553643 - IRNA AGENTS TARGETING VEGF.
HI963349 - Sequence 279 from Patent EP1735009.
HV496588 - JP 2011518117-A/1816: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982971 - JP 2011188866-A/279: IRNA AGENTS TARGETING VEGF.
HZ402105 - JP 2015177801-A/1816: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420202 - JP 2014094020-A/279: IRNA AGENTS TARGETING VEGF.
LZ247373 - JP 2016135144-A/279: IRNA AGENTS TARGETING VEGF.
FW553644 - IRNA AGENTS TARGETING VEGF.
HI963350 - Sequence 280 from Patent EP1735009.
HV496589 - JP 2011518117-A/1817: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497010 - JP 2011518117-A/2238: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982972 - JP 2011188866-A/280: IRNA AGENTS TARGETING VEGF.
HZ402106 - JP 2015177801-A/1817: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402527 - JP 2015177801-A/2238: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420203 - JP 2014094020-A/280: IRNA AGENTS TARGETING VEGF.
LZ247374 - JP 2016135144-A/280: IRNA AGENTS TARGETING VEGF.
FW553645 - IRNA AGENTS TARGETING VEGF.
HI963351 - Sequence 281 from Patent EP1735009.
HV496590 - JP 2011518117-A/1818: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982973 - JP 2011188866-A/281: IRNA AGENTS TARGETING VEGF.
HZ402107 - JP 2015177801-A/1818: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420204 - JP 2014094020-A/281: IRNA AGENTS TARGETING VEGF.
LZ247375 - JP 2016135144-A/281: IRNA AGENTS TARGETING VEGF.
FW553646 - IRNA AGENTS TARGETING VEGF.
HI963352 - Sequence 282 from Patent EP1735009.
HV496591 - JP 2011518117-A/1819: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497011 - JP 2011518117-A/2239: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982974 - JP 2011188866-A/282: IRNA AGENTS TARGETING VEGF.
HZ402108 - JP 2015177801-A/1819: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402528 - JP 2015177801-A/2239: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420205 - JP 2014094020-A/282: IRNA AGENTS TARGETING VEGF.
LZ247376 - JP 2016135144-A/282: IRNA AGENTS TARGETING VEGF.
FW553647 - IRNA AGENTS TARGETING VEGF.
HI963353 - Sequence 283 from Patent EP1735009.
HV496592 - JP 2011518117-A/1820: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982975 - JP 2011188866-A/283: IRNA AGENTS TARGETING VEGF.
HZ402109 - JP 2015177801-A/1820: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420206 - JP 2014094020-A/283: IRNA AGENTS TARGETING VEGF.
LZ247377 - JP 2016135144-A/283: IRNA AGENTS TARGETING VEGF.
FW553648 - IRNA AGENTS TARGETING VEGF.
HI963354 - Sequence 284 from Patent EP1735009.
HV496593 - JP 2011518117-A/1821: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497012 - JP 2011518117-A/2240: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982976 - JP 2011188866-A/284: IRNA AGENTS TARGETING VEGF.
HZ402110 - JP 2015177801-A/1821: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402529 - JP 2015177801-A/2240: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420207 - JP 2014094020-A/284: IRNA AGENTS TARGETING VEGF.
LZ247378 - JP 2016135144-A/284: IRNA AGENTS TARGETING VEGF.
FW553649 - IRNA AGENTS TARGETING VEGF.
HI963355 - Sequence 285 from Patent EP1735009.
HV496594 - JP 2011518117-A/1822: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982977 - JP 2011188866-A/285: IRNA AGENTS TARGETING VEGF.
HZ402111 - JP 2015177801-A/1822: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420208 - JP 2014094020-A/285: IRNA AGENTS TARGETING VEGF.
LZ247379 - JP 2016135144-A/285: IRNA AGENTS TARGETING VEGF.
FW553650 - IRNA AGENTS TARGETING VEGF.
HI963356 - Sequence 286 from Patent EP1735009.
HV496595 - JP 2011518117-A/1823: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982978 - JP 2011188866-A/286: IRNA AGENTS TARGETING VEGF.
HZ402112 - JP 2015177801-A/1823: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420209 - JP 2014094020-A/286: IRNA AGENTS TARGETING VEGF.
LZ247380 - JP 2016135144-A/286: IRNA AGENTS TARGETING VEGF.
FW553651 - IRNA AGENTS TARGETING VEGF.
HI963357 - Sequence 287 from Patent EP1735009.
HV496596 - JP 2011518117-A/1824: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982979 - JP 2011188866-A/287: IRNA AGENTS TARGETING VEGF.
HZ402113 - JP 2015177801-A/1824: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420210 - JP 2014094020-A/287: IRNA AGENTS TARGETING VEGF.
LZ247381 - JP 2016135144-A/287: IRNA AGENTS TARGETING VEGF.
FW553652 - IRNA AGENTS TARGETING VEGF.
HI963358 - Sequence 288 from Patent EP1735009.
HV496597 - JP 2011518117-A/1825: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982980 - JP 2011188866-A/288: IRNA AGENTS TARGETING VEGF.
HZ402114 - JP 2015177801-A/1825: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420211 - JP 2014094020-A/288: IRNA AGENTS TARGETING VEGF.
LZ247382 - JP 2016135144-A/288: IRNA AGENTS TARGETING VEGF.
FW553653 - IRNA AGENTS TARGETING VEGF.
HI963359 - Sequence 289 from Patent EP1735009.
HV496598 - JP 2011518117-A/1826: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982981 - JP 2011188866-A/289: IRNA AGENTS TARGETING VEGF.
HZ402115 - JP 2015177801-A/1826: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420212 - JP 2014094020-A/289: IRNA AGENTS TARGETING VEGF.
LZ247383 - JP 2016135144-A/289: IRNA AGENTS TARGETING VEGF.
FW553654 - IRNA AGENTS TARGETING VEGF.
HI963360 - Sequence 290 from Patent EP1735009.
HV496599 - JP 2011518117-A/1827: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497013 - JP 2011518117-A/2241: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982982 - JP 2011188866-A/290: IRNA AGENTS TARGETING VEGF.
HZ402116 - JP 2015177801-A/1827: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402530 - JP 2015177801-A/2241: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420213 - JP 2014094020-A/290: IRNA AGENTS TARGETING VEGF.
LZ247384 - JP 2016135144-A/290: IRNA AGENTS TARGETING VEGF.
FW553655 - IRNA AGENTS TARGETING VEGF.
HI963361 - Sequence 291 from Patent EP1735009.
HV496600 - JP 2011518117-A/1828: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982983 - JP 2011188866-A/291: IRNA AGENTS TARGETING VEGF.
HZ402117 - JP 2015177801-A/1828: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420214 - JP 2014094020-A/291: IRNA AGENTS TARGETING VEGF.
LZ247385 - JP 2016135144-A/291: IRNA AGENTS TARGETING VEGF.
FW553656 - IRNA AGENTS TARGETING VEGF.
HI963362 - Sequence 292 from Patent EP1735009.
HV496601 - JP 2011518117-A/1829: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982984 - JP 2011188866-A/292: IRNA AGENTS TARGETING VEGF.
HZ402118 - JP 2015177801-A/1829: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420215 - JP 2014094020-A/292: IRNA AGENTS TARGETING VEGF.
LZ247386 - JP 2016135144-A/292: IRNA AGENTS TARGETING VEGF.
FW553657 - IRNA AGENTS TARGETING VEGF.
HI963363 - Sequence 293 from Patent EP1735009.
HV496602 - JP 2011518117-A/1830: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982985 - JP 2011188866-A/293: IRNA AGENTS TARGETING VEGF.
HZ402119 - JP 2015177801-A/1830: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420216 - JP 2014094020-A/293: IRNA AGENTS TARGETING VEGF.
LZ247387 - JP 2016135144-A/293: IRNA AGENTS TARGETING VEGF.
FW553658 - IRNA AGENTS TARGETING VEGF.
HI963364 - Sequence 294 from Patent EP1735009.
HV496603 - JP 2011518117-A/1831: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982986 - JP 2011188866-A/294: IRNA AGENTS TARGETING VEGF.
HZ402120 - JP 2015177801-A/1831: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420217 - JP 2014094020-A/294: IRNA AGENTS TARGETING VEGF.
LZ247388 - JP 2016135144-A/294: IRNA AGENTS TARGETING VEGF.
FW553659 - IRNA AGENTS TARGETING VEGF.
HI963365 - Sequence 295 from Patent EP1735009.
HV496604 - JP 2011518117-A/1832: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982987 - JP 2011188866-A/295: IRNA AGENTS TARGETING VEGF.
HZ402121 - JP 2015177801-A/1832: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420218 - JP 2014094020-A/295: IRNA AGENTS TARGETING VEGF.
LZ247389 - JP 2016135144-A/295: IRNA AGENTS TARGETING VEGF.
FW553660 - IRNA AGENTS TARGETING VEGF.
HI963366 - Sequence 296 from Patent EP1735009.
HV496605 - JP 2011518117-A/1833: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV982988 - JP 2011188866-A/296: IRNA AGENTS TARGETING VEGF.
HZ402122 - JP 2015177801-A/1833: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420219 - JP 2014094020-A/296: IRNA AGENTS TARGETING VEGF.
LZ247390 - JP 2016135144-A/296: IRNA AGENTS TARGETING VEGF.
AK098750 - Homo sapiens cDNA FLJ25884 fis, clone CBR02931.
AF323587 - Homo sapiens vascular endothelial growth factor 41 (VEGF41) mRNA, complete cds.
FW553676 - IRNA AGENTS TARGETING VEGF.
HI963382 - Sequence 312 from Patent EP1735009.
HV496621 - JP 2011518117-A/1849: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983004 - JP 2011188866-A/312: IRNA AGENTS TARGETING VEGF.
HZ402138 - JP 2015177801-A/1849: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420235 - JP 2014094020-A/312: IRNA AGENTS TARGETING VEGF.
LZ247406 - JP 2016135144-A/312: IRNA AGENTS TARGETING VEGF.
FW553677 - IRNA AGENTS TARGETING VEGF.
HI963383 - Sequence 313 from Patent EP1735009.
HV496622 - JP 2011518117-A/1850: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497017 - JP 2011518117-A/2245: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983005 - JP 2011188866-A/313: IRNA AGENTS TARGETING VEGF.
HZ402139 - JP 2015177801-A/1850: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402534 - JP 2015177801-A/2245: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420236 - JP 2014094020-A/313: IRNA AGENTS TARGETING VEGF.
LZ247407 - JP 2016135144-A/313: IRNA AGENTS TARGETING VEGF.
FW553678 - IRNA AGENTS TARGETING VEGF.
HI963384 - Sequence 314 from Patent EP1735009.
HV496623 - JP 2011518117-A/1851: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983006 - JP 2011188866-A/314: IRNA AGENTS TARGETING VEGF.
HZ402140 - JP 2015177801-A/1851: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420237 - JP 2014094020-A/314: IRNA AGENTS TARGETING VEGF.
LZ247408 - JP 2016135144-A/314: IRNA AGENTS TARGETING VEGF.
FW553679 - IRNA AGENTS TARGETING VEGF.
HI963385 - Sequence 315 from Patent EP1735009.
HV496624 - JP 2011518117-A/1852: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983007 - JP 2011188866-A/315: IRNA AGENTS TARGETING VEGF.
HZ402141 - JP 2015177801-A/1852: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420238 - JP 2014094020-A/315: IRNA AGENTS TARGETING VEGF.
LZ247409 - JP 2016135144-A/315: IRNA AGENTS TARGETING VEGF.
FW553680 - IRNA AGENTS TARGETING VEGF.
HI963386 - Sequence 316 from Patent EP1735009.
HV496625 - JP 2011518117-A/1853: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497018 - JP 2011518117-A/2246: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983008 - JP 2011188866-A/316: IRNA AGENTS TARGETING VEGF.
HZ402142 - JP 2015177801-A/1853: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402535 - JP 2015177801-A/2246: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420239 - JP 2014094020-A/316: IRNA AGENTS TARGETING VEGF.
LZ247410 - JP 2016135144-A/316: IRNA AGENTS TARGETING VEGF.
FW553681 - IRNA AGENTS TARGETING VEGF.
HI963387 - Sequence 317 from Patent EP1735009.
HV496626 - JP 2011518117-A/1854: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497019 - JP 2011518117-A/2247: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983009 - JP 2011188866-A/317: IRNA AGENTS TARGETING VEGF.
HZ402143 - JP 2015177801-A/1854: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402536 - JP 2015177801-A/2247: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420240 - JP 2014094020-A/317: IRNA AGENTS TARGETING VEGF.
LZ247411 - JP 2016135144-A/317: IRNA AGENTS TARGETING VEGF.
FW553682 - IRNA AGENTS TARGETING VEGF.
HI963388 - Sequence 318 from Patent EP1735009.
HV496627 - JP 2011518117-A/1855: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497020 - JP 2011518117-A/2248: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983010 - JP 2011188866-A/318: IRNA AGENTS TARGETING VEGF.
HZ402144 - JP 2015177801-A/1855: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402537 - JP 2015177801-A/2248: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420241 - JP 2014094020-A/318: IRNA AGENTS TARGETING VEGF.
LZ247412 - JP 2016135144-A/318: IRNA AGENTS TARGETING VEGF.
FW553683 - IRNA AGENTS TARGETING VEGF.
HI963389 - Sequence 319 from Patent EP1735009.
HV496628 - JP 2011518117-A/1856: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983011 - JP 2011188866-A/319: IRNA AGENTS TARGETING VEGF.
HZ402145 - JP 2015177801-A/1856: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420242 - JP 2014094020-A/319: IRNA AGENTS TARGETING VEGF.
LZ247413 - JP 2016135144-A/319: IRNA AGENTS TARGETING VEGF.
FW553684 - IRNA AGENTS TARGETING VEGF.
HI963390 - Sequence 320 from Patent EP1735009.
HV496629 - JP 2011518117-A/1857: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497021 - JP 2011518117-A/2249: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983012 - JP 2011188866-A/320: IRNA AGENTS TARGETING VEGF.
HZ402146 - JP 2015177801-A/1857: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402538 - JP 2015177801-A/2249: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420243 - JP 2014094020-A/320: IRNA AGENTS TARGETING VEGF.
LZ247414 - JP 2016135144-A/320: IRNA AGENTS TARGETING VEGF.
FW553685 - IRNA AGENTS TARGETING VEGF.
HI963391 - Sequence 321 from Patent EP1735009.
HV496630 - JP 2011518117-A/1858: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983013 - JP 2011188866-A/321: IRNA AGENTS TARGETING VEGF.
HZ402147 - JP 2015177801-A/1858: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420244 - JP 2014094020-A/321: IRNA AGENTS TARGETING VEGF.
LZ247415 - JP 2016135144-A/321: IRNA AGENTS TARGETING VEGF.
FW553686 - IRNA AGENTS TARGETING VEGF.
HI963392 - Sequence 322 from Patent EP1735009.
HV496631 - JP 2011518117-A/1859: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497022 - JP 2011518117-A/2250: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983014 - JP 2011188866-A/322: IRNA AGENTS TARGETING VEGF.
HZ402148 - JP 2015177801-A/1859: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402539 - JP 2015177801-A/2250: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420245 - JP 2014094020-A/322: IRNA AGENTS TARGETING VEGF.
LZ247416 - JP 2016135144-A/322: IRNA AGENTS TARGETING VEGF.
FW553687 - IRNA AGENTS TARGETING VEGF.
HI963393 - Sequence 323 from Patent EP1735009.
HV496632 - JP 2011518117-A/1860: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983015 - JP 2011188866-A/323: IRNA AGENTS TARGETING VEGF.
HZ402149 - JP 2015177801-A/1860: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420246 - JP 2014094020-A/323: IRNA AGENTS TARGETING VEGF.
LZ247417 - JP 2016135144-A/323: IRNA AGENTS TARGETING VEGF.
FW553688 - IRNA AGENTS TARGETING VEGF.
HI963394 - Sequence 324 from Patent EP1735009.
HV496633 - JP 2011518117-A/1861: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983016 - JP 2011188866-A/324: IRNA AGENTS TARGETING VEGF.
HZ402150 - JP 2015177801-A/1861: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420247 - JP 2014094020-A/324: IRNA AGENTS TARGETING VEGF.
LZ247418 - JP 2016135144-A/324: IRNA AGENTS TARGETING VEGF.
FW553689 - IRNA AGENTS TARGETING VEGF.
HI963395 - Sequence 325 from Patent EP1735009.
HV496634 - JP 2011518117-A/1862: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983017 - JP 2011188866-A/325: IRNA AGENTS TARGETING VEGF.
HZ402151 - JP 2015177801-A/1862: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420248 - JP 2014094020-A/325: IRNA AGENTS TARGETING VEGF.
LZ247419 - JP 2016135144-A/325: IRNA AGENTS TARGETING VEGF.
FW553690 - IRNA AGENTS TARGETING VEGF.
HI963396 - Sequence 326 from Patent EP1735009.
HV496635 - JP 2011518117-A/1863: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983018 - JP 2011188866-A/326: IRNA AGENTS TARGETING VEGF.
HZ402152 - JP 2015177801-A/1863: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420249 - JP 2014094020-A/326: IRNA AGENTS TARGETING VEGF.
LZ247420 - JP 2016135144-A/326: IRNA AGENTS TARGETING VEGF.
FW553691 - IRNA AGENTS TARGETING VEGF.
HI963397 - Sequence 327 from Patent EP1735009.
HV496636 - JP 2011518117-A/1864: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983019 - JP 2011188866-A/327: IRNA AGENTS TARGETING VEGF.
HZ402153 - JP 2015177801-A/1864: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420250 - JP 2014094020-A/327: IRNA AGENTS TARGETING VEGF.
LZ247421 - JP 2016135144-A/327: IRNA AGENTS TARGETING VEGF.
FW553692 - IRNA AGENTS TARGETING VEGF.
HI963398 - Sequence 328 from Patent EP1735009.
HV496637 - JP 2011518117-A/1865: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983020 - JP 2011188866-A/328: IRNA AGENTS TARGETING VEGF.
HZ402154 - JP 2015177801-A/1865: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420251 - JP 2014094020-A/328: IRNA AGENTS TARGETING VEGF.
LZ247422 - JP 2016135144-A/328: IRNA AGENTS TARGETING VEGF.
FW553693 - IRNA AGENTS TARGETING VEGF.
HI963399 - Sequence 329 from Patent EP1735009.
HV496638 - JP 2011518117-A/1866: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983021 - JP 2011188866-A/329: IRNA AGENTS TARGETING VEGF.
HZ402155 - JP 2015177801-A/1866: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420252 - JP 2014094020-A/329: IRNA AGENTS TARGETING VEGF.
LZ247423 - JP 2016135144-A/329: IRNA AGENTS TARGETING VEGF.
FW553694 - IRNA AGENTS TARGETING VEGF.
HI963400 - Sequence 330 from Patent EP1735009.
HV496639 - JP 2011518117-A/1867: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983022 - JP 2011188866-A/330: IRNA AGENTS TARGETING VEGF.
HZ402156 - JP 2015177801-A/1867: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420253 - JP 2014094020-A/330: IRNA AGENTS TARGETING VEGF.
LZ247424 - JP 2016135144-A/330: IRNA AGENTS TARGETING VEGF.
FW553695 - IRNA AGENTS TARGETING VEGF.
HI963401 - Sequence 331 from Patent EP1735009.
HV496640 - JP 2011518117-A/1868: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983023 - JP 2011188866-A/331: IRNA AGENTS TARGETING VEGF.
HZ402157 - JP 2015177801-A/1868: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420254 - JP 2014094020-A/331: IRNA AGENTS TARGETING VEGF.
LZ247425 - JP 2016135144-A/331: IRNA AGENTS TARGETING VEGF.
FW553696 - IRNA AGENTS TARGETING VEGF.
HI963402 - Sequence 332 from Patent EP1735009.
HV496641 - JP 2011518117-A/1869: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983024 - JP 2011188866-A/332: IRNA AGENTS TARGETING VEGF.
HZ402158 - JP 2015177801-A/1869: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420255 - JP 2014094020-A/332: IRNA AGENTS TARGETING VEGF.
LZ247426 - JP 2016135144-A/332: IRNA AGENTS TARGETING VEGF.
FW553697 - IRNA AGENTS TARGETING VEGF.
HI963403 - Sequence 333 from Patent EP1735009.
HV496642 - JP 2011518117-A/1870: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983025 - JP 2011188866-A/333: IRNA AGENTS TARGETING VEGF.
HZ402159 - JP 2015177801-A/1870: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420256 - JP 2014094020-A/333: IRNA AGENTS TARGETING VEGF.
LZ247427 - JP 2016135144-A/333: IRNA AGENTS TARGETING VEGF.
FW553698 - IRNA AGENTS TARGETING VEGF.
HI963404 - Sequence 334 from Patent EP1735009.
HV496643 - JP 2011518117-A/1871: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983026 - JP 2011188866-A/334: IRNA AGENTS TARGETING VEGF.
HZ402160 - JP 2015177801-A/1871: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420257 - JP 2014094020-A/334: IRNA AGENTS TARGETING VEGF.
LZ247428 - JP 2016135144-A/334: IRNA AGENTS TARGETING VEGF.
FW553699 - IRNA AGENTS TARGETING VEGF.
HI963405 - Sequence 335 from Patent EP1735009.
HV496644 - JP 2011518117-A/1872: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983027 - JP 2011188866-A/335: IRNA AGENTS TARGETING VEGF.
HZ402161 - JP 2015177801-A/1872: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420258 - JP 2014094020-A/335: IRNA AGENTS TARGETING VEGF.
LZ247429 - JP 2016135144-A/335: IRNA AGENTS TARGETING VEGF.
FW553700 - IRNA AGENTS TARGETING VEGF.
HI963406 - Sequence 336 from Patent EP1735009.
HV496645 - JP 2011518117-A/1873: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983028 - JP 2011188866-A/336: IRNA AGENTS TARGETING VEGF.
HZ402162 - JP 2015177801-A/1873: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420259 - JP 2014094020-A/336: IRNA AGENTS TARGETING VEGF.
LZ247430 - JP 2016135144-A/336: IRNA AGENTS TARGETING VEGF.
FW553701 - IRNA AGENTS TARGETING VEGF.
HI963407 - Sequence 337 from Patent EP1735009.
HV496646 - JP 2011518117-A/1874: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983029 - JP 2011188866-A/337: IRNA AGENTS TARGETING VEGF.
HZ402163 - JP 2015177801-A/1874: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420260 - JP 2014094020-A/337: IRNA AGENTS TARGETING VEGF.
LZ247431 - JP 2016135144-A/337: IRNA AGENTS TARGETING VEGF.
FW553702 - IRNA AGENTS TARGETING VEGF.
HI963408 - Sequence 338 from Patent EP1735009.
HV496647 - JP 2011518117-A/1875: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983030 - JP 2011188866-A/338: IRNA AGENTS TARGETING VEGF.
HZ402164 - JP 2015177801-A/1875: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420261 - JP 2014094020-A/338: IRNA AGENTS TARGETING VEGF.
LZ247432 - JP 2016135144-A/338: IRNA AGENTS TARGETING VEGF.
FW553703 - IRNA AGENTS TARGETING VEGF.
HI963409 - Sequence 339 from Patent EP1735009.
HV496648 - JP 2011518117-A/1876: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983031 - JP 2011188866-A/339: IRNA AGENTS TARGETING VEGF.
HZ402165 - JP 2015177801-A/1876: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420262 - JP 2014094020-A/339: IRNA AGENTS TARGETING VEGF.
LZ247433 - JP 2016135144-A/339: IRNA AGENTS TARGETING VEGF.
FW553704 - IRNA AGENTS TARGETING VEGF.
HI963410 - Sequence 340 from Patent EP1735009.
HV496649 - JP 2011518117-A/1877: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983032 - JP 2011188866-A/340: IRNA AGENTS TARGETING VEGF.
HZ402166 - JP 2015177801-A/1877: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420263 - JP 2014094020-A/340: IRNA AGENTS TARGETING VEGF.
LZ247434 - JP 2016135144-A/340: IRNA AGENTS TARGETING VEGF.
FW553705 - IRNA AGENTS TARGETING VEGF.
HI963411 - Sequence 341 from Patent EP1735009.
HV496650 - JP 2011518117-A/1878: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983033 - JP 2011188866-A/341: IRNA AGENTS TARGETING VEGF.
HZ402167 - JP 2015177801-A/1878: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420264 - JP 2014094020-A/341: IRNA AGENTS TARGETING VEGF.
LZ247435 - JP 2016135144-A/341: IRNA AGENTS TARGETING VEGF.
AF062645 - Homo sapiens vascular endothelial growth factor 183 mRNA, partial cds.
FW553706 - IRNA AGENTS TARGETING VEGF.
HI963412 - Sequence 342 from Patent EP1735009.
HV496651 - JP 2011518117-A/1879: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497023 - JP 2011518117-A/2251: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983034 - JP 2011188866-A/342: IRNA AGENTS TARGETING VEGF.
HZ402168 - JP 2015177801-A/1879: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402540 - JP 2015177801-A/2251: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420265 - JP 2014094020-A/342: IRNA AGENTS TARGETING VEGF.
LZ247436 - JP 2016135144-A/342: IRNA AGENTS TARGETING VEGF.
FW553707 - IRNA AGENTS TARGETING VEGF.
HI963413 - Sequence 343 from Patent EP1735009.
HV496652 - JP 2011518117-A/1880: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497024 - JP 2011518117-A/2252: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983035 - JP 2011188866-A/343: IRNA AGENTS TARGETING VEGF.
HZ402169 - JP 2015177801-A/1880: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402541 - JP 2015177801-A/2252: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420266 - JP 2014094020-A/343: IRNA AGENTS TARGETING VEGF.
LZ247437 - JP 2016135144-A/343: IRNA AGENTS TARGETING VEGF.
FW553708 - IRNA AGENTS TARGETING VEGF.
HI963414 - Sequence 344 from Patent EP1735009.
HV496653 - JP 2011518117-A/1881: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497025 - JP 2011518117-A/2253: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983036 - JP 2011188866-A/344: IRNA AGENTS TARGETING VEGF.
HZ402170 - JP 2015177801-A/1881: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402542 - JP 2015177801-A/2253: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420267 - JP 2014094020-A/344: IRNA AGENTS TARGETING VEGF.
LZ247438 - JP 2016135144-A/344: IRNA AGENTS TARGETING VEGF.
FW553709 - IRNA AGENTS TARGETING VEGF.
HI963415 - Sequence 345 from Patent EP1735009.
HV496654 - JP 2011518117-A/1882: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497026 - JP 2011518117-A/2254: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983037 - JP 2011188866-A/345: IRNA AGENTS TARGETING VEGF.
HZ402171 - JP 2015177801-A/1882: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402543 - JP 2015177801-A/2254: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420268 - JP 2014094020-A/345: IRNA AGENTS TARGETING VEGF.
LZ247439 - JP 2016135144-A/345: IRNA AGENTS TARGETING VEGF.
FW553710 - IRNA AGENTS TARGETING VEGF.
HI963416 - Sequence 346 from Patent EP1735009.
HV496655 - JP 2011518117-A/1883: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983038 - JP 2011188866-A/346: IRNA AGENTS TARGETING VEGF.
HZ402172 - JP 2015177801-A/1883: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420269 - JP 2014094020-A/346: IRNA AGENTS TARGETING VEGF.
LZ247440 - JP 2016135144-A/346: IRNA AGENTS TARGETING VEGF.
FW553711 - IRNA AGENTS TARGETING VEGF.
HI963417 - Sequence 347 from Patent EP1735009.
HV496656 - JP 2011518117-A/1884: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497027 - JP 2011518117-A/2255: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983039 - JP 2011188866-A/347: IRNA AGENTS TARGETING VEGF.
HZ402173 - JP 2015177801-A/1884: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402544 - JP 2015177801-A/2255: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420270 - JP 2014094020-A/347: IRNA AGENTS TARGETING VEGF.
LZ247441 - JP 2016135144-A/347: IRNA AGENTS TARGETING VEGF.
FW553712 - IRNA AGENTS TARGETING VEGF.
HI963418 - Sequence 348 from Patent EP1735009.
HV496657 - JP 2011518117-A/1885: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983040 - JP 2011188866-A/348: IRNA AGENTS TARGETING VEGF.
HZ402174 - JP 2015177801-A/1885: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420271 - JP 2014094020-A/348: IRNA AGENTS TARGETING VEGF.
LZ247442 - JP 2016135144-A/348: IRNA AGENTS TARGETING VEGF.
FW553713 - IRNA AGENTS TARGETING VEGF.
HI963419 - Sequence 349 from Patent EP1735009.
HV496658 - JP 2011518117-A/1886: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983041 - JP 2011188866-A/349: IRNA AGENTS TARGETING VEGF.
HZ402175 - JP 2015177801-A/1886: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420272 - JP 2014094020-A/349: IRNA AGENTS TARGETING VEGF.
LZ247443 - JP 2016135144-A/349: IRNA AGENTS TARGETING VEGF.
FW553714 - IRNA AGENTS TARGETING VEGF.
HI963420 - Sequence 350 from Patent EP1735009.
HV496659 - JP 2011518117-A/1887: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497028 - JP 2011518117-A/2256: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983042 - JP 2011188866-A/350: IRNA AGENTS TARGETING VEGF.
HZ402176 - JP 2015177801-A/1887: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402545 - JP 2015177801-A/2256: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420273 - JP 2014094020-A/350: IRNA AGENTS TARGETING VEGF.
LZ247444 - JP 2016135144-A/350: IRNA AGENTS TARGETING VEGF.
FW553715 - IRNA AGENTS TARGETING VEGF.
HI963421 - Sequence 351 from Patent EP1735009.
HV496660 - JP 2011518117-A/1888: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983043 - JP 2011188866-A/351: IRNA AGENTS TARGETING VEGF.
HZ402177 - JP 2015177801-A/1888: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420274 - JP 2014094020-A/351: IRNA AGENTS TARGETING VEGF.
LZ247445 - JP 2016135144-A/351: IRNA AGENTS TARGETING VEGF.
FW553716 - IRNA AGENTS TARGETING VEGF.
HI963422 - Sequence 352 from Patent EP1735009.
HV496661 - JP 2011518117-A/1889: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983044 - JP 2011188866-A/352: IRNA AGENTS TARGETING VEGF.
HZ402178 - JP 2015177801-A/1889: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420275 - JP 2014094020-A/352: IRNA AGENTS TARGETING VEGF.
LZ247446 - JP 2016135144-A/352: IRNA AGENTS TARGETING VEGF.
FW553717 - IRNA AGENTS TARGETING VEGF.
HI963423 - Sequence 353 from Patent EP1735009.
HV496662 - JP 2011518117-A/1890: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983045 - JP 2011188866-A/353: IRNA AGENTS TARGETING VEGF.
HZ402179 - JP 2015177801-A/1890: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420276 - JP 2014094020-A/353: IRNA AGENTS TARGETING VEGF.
LZ247447 - JP 2016135144-A/353: IRNA AGENTS TARGETING VEGF.
FW553718 - IRNA AGENTS TARGETING VEGF.
HI963424 - Sequence 354 from Patent EP1735009.
HV496663 - JP 2011518117-A/1891: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983046 - JP 2011188866-A/354: IRNA AGENTS TARGETING VEGF.
HZ402180 - JP 2015177801-A/1891: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420277 - JP 2014094020-A/354: IRNA AGENTS TARGETING VEGF.
LZ247448 - JP 2016135144-A/354: IRNA AGENTS TARGETING VEGF.
FW553719 - IRNA AGENTS TARGETING VEGF.
HI963425 - Sequence 355 from Patent EP1735009.
HV496664 - JP 2011518117-A/1892: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983047 - JP 2011188866-A/355: IRNA AGENTS TARGETING VEGF.
HZ402181 - JP 2015177801-A/1892: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420278 - JP 2014094020-A/355: IRNA AGENTS TARGETING VEGF.
LZ247449 - JP 2016135144-A/355: IRNA AGENTS TARGETING VEGF.
FW553720 - IRNA AGENTS TARGETING VEGF.
HI963426 - Sequence 356 from Patent EP1735009.
HV496665 - JP 2011518117-A/1893: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983048 - JP 2011188866-A/356: IRNA AGENTS TARGETING VEGF.
HZ402182 - JP 2015177801-A/1893: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420279 - JP 2014094020-A/356: IRNA AGENTS TARGETING VEGF.
LZ247450 - JP 2016135144-A/356: IRNA AGENTS TARGETING VEGF.
FW553721 - IRNA AGENTS TARGETING VEGF.
HI963427 - Sequence 357 from Patent EP1735009.
HV496666 - JP 2011518117-A/1894: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983049 - JP 2011188866-A/357: IRNA AGENTS TARGETING VEGF.
HZ402183 - JP 2015177801-A/1894: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420280 - JP 2014094020-A/357: IRNA AGENTS TARGETING VEGF.
LZ247451 - JP 2016135144-A/357: IRNA AGENTS TARGETING VEGF.
FW553722 - IRNA AGENTS TARGETING VEGF.
HI963428 - Sequence 358 from Patent EP1735009.
HV496667 - JP 2011518117-A/1895: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983050 - JP 2011188866-A/358: IRNA AGENTS TARGETING VEGF.
HZ402184 - JP 2015177801-A/1895: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420281 - JP 2014094020-A/358: IRNA AGENTS TARGETING VEGF.
LZ247452 - JP 2016135144-A/358: IRNA AGENTS TARGETING VEGF.
FW553723 - IRNA AGENTS TARGETING VEGF.
HI963429 - Sequence 359 from Patent EP1735009.
HV496668 - JP 2011518117-A/1896: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983051 - JP 2011188866-A/359: IRNA AGENTS TARGETING VEGF.
HZ402185 - JP 2015177801-A/1896: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420282 - JP 2014094020-A/359: IRNA AGENTS TARGETING VEGF.
LZ247453 - JP 2016135144-A/359: IRNA AGENTS TARGETING VEGF.
FW553724 - IRNA AGENTS TARGETING VEGF.
HI963430 - Sequence 360 from Patent EP1735009.
HV496669 - JP 2011518117-A/1897: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983052 - JP 2011188866-A/360: IRNA AGENTS TARGETING VEGF.
HZ402186 - JP 2015177801-A/1897: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420283 - JP 2014094020-A/360: IRNA AGENTS TARGETING VEGF.
LZ247454 - JP 2016135144-A/360: IRNA AGENTS TARGETING VEGF.
FW553725 - IRNA AGENTS TARGETING VEGF.
HI963431 - Sequence 361 from Patent EP1735009.
HV496670 - JP 2011518117-A/1898: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983053 - JP 2011188866-A/361: IRNA AGENTS TARGETING VEGF.
HZ402187 - JP 2015177801-A/1898: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420284 - JP 2014094020-A/361: IRNA AGENTS TARGETING VEGF.
LZ247455 - JP 2016135144-A/361: IRNA AGENTS TARGETING VEGF.
FW553726 - IRNA AGENTS TARGETING VEGF.
HI963432 - Sequence 362 from Patent EP1735009.
HV496671 - JP 2011518117-A/1899: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983054 - JP 2011188866-A/362: IRNA AGENTS TARGETING VEGF.
HZ402188 - JP 2015177801-A/1899: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420285 - JP 2014094020-A/362: IRNA AGENTS TARGETING VEGF.
LZ247456 - JP 2016135144-A/362: IRNA AGENTS TARGETING VEGF.
FW553727 - IRNA AGENTS TARGETING VEGF.
HI963433 - Sequence 363 from Patent EP1735009.
HV496672 - JP 2011518117-A/1900: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983055 - JP 2011188866-A/363: IRNA AGENTS TARGETING VEGF.
HZ402189 - JP 2015177801-A/1900: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420286 - JP 2014094020-A/363: IRNA AGENTS TARGETING VEGF.
LZ247457 - JP 2016135144-A/363: IRNA AGENTS TARGETING VEGF.
FW553728 - IRNA AGENTS TARGETING VEGF.
HI963434 - Sequence 364 from Patent EP1735009.
HV496673 - JP 2011518117-A/1901: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983056 - JP 2011188866-A/364: IRNA AGENTS TARGETING VEGF.
HZ402190 - JP 2015177801-A/1901: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420287 - JP 2014094020-A/364: IRNA AGENTS TARGETING VEGF.
LZ247458 - JP 2016135144-A/364: IRNA AGENTS TARGETING VEGF.
FW553729 - IRNA AGENTS TARGETING VEGF.
HI963435 - Sequence 365 from Patent EP1735009.
HV496674 - JP 2011518117-A/1902: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983057 - JP 2011188866-A/365: IRNA AGENTS TARGETING VEGF.
HZ402191 - JP 2015177801-A/1902: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420288 - JP 2014094020-A/365: IRNA AGENTS TARGETING VEGF.
LZ247459 - JP 2016135144-A/365: IRNA AGENTS TARGETING VEGF.
FW553730 - IRNA AGENTS TARGETING VEGF.
HI963436 - Sequence 366 from Patent EP1735009.
HV496675 - JP 2011518117-A/1903: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983058 - JP 2011188866-A/366: IRNA AGENTS TARGETING VEGF.
HZ402192 - JP 2015177801-A/1903: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420289 - JP 2014094020-A/366: IRNA AGENTS TARGETING VEGF.
LZ247460 - JP 2016135144-A/366: IRNA AGENTS TARGETING VEGF.
FW553731 - IRNA AGENTS TARGETING VEGF.
HI963437 - Sequence 367 from Patent EP1735009.
HV496676 - JP 2011518117-A/1904: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983059 - JP 2011188866-A/367: IRNA AGENTS TARGETING VEGF.
HZ402193 - JP 2015177801-A/1904: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420290 - JP 2014094020-A/367: IRNA AGENTS TARGETING VEGF.
LZ247461 - JP 2016135144-A/367: IRNA AGENTS TARGETING VEGF.
FW553732 - IRNA AGENTS TARGETING VEGF.
HI963438 - Sequence 368 from Patent EP1735009.
HV496677 - JP 2011518117-A/1905: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983060 - JP 2011188866-A/368: IRNA AGENTS TARGETING VEGF.
HZ402194 - JP 2015177801-A/1905: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420291 - JP 2014094020-A/368: IRNA AGENTS TARGETING VEGF.
LZ247462 - JP 2016135144-A/368: IRNA AGENTS TARGETING VEGF.
FW553733 - IRNA AGENTS TARGETING VEGF.
HI963439 - Sequence 369 from Patent EP1735009.
HV496678 - JP 2011518117-A/1906: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983061 - JP 2011188866-A/369: IRNA AGENTS TARGETING VEGF.
HZ402195 - JP 2015177801-A/1906: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420292 - JP 2014094020-A/369: IRNA AGENTS TARGETING VEGF.
LZ247463 - JP 2016135144-A/369: IRNA AGENTS TARGETING VEGF.
FW553734 - IRNA AGENTS TARGETING VEGF.
HI963440 - Sequence 370 from Patent EP1735009.
HV496679 - JP 2011518117-A/1907: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497029 - JP 2011518117-A/2257: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983062 - JP 2011188866-A/370: IRNA AGENTS TARGETING VEGF.
HZ402196 - JP 2015177801-A/1907: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402546 - JP 2015177801-A/2257: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420293 - JP 2014094020-A/370: IRNA AGENTS TARGETING VEGF.
LZ247464 - JP 2016135144-A/370: IRNA AGENTS TARGETING VEGF.
FW553735 - IRNA AGENTS TARGETING VEGF.
HI963441 - Sequence 371 from Patent EP1735009.
HV496680 - JP 2011518117-A/1908: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983063 - JP 2011188866-A/371: IRNA AGENTS TARGETING VEGF.
HZ402197 - JP 2015177801-A/1908: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420294 - JP 2014094020-A/371: IRNA AGENTS TARGETING VEGF.
LZ247465 - JP 2016135144-A/371: IRNA AGENTS TARGETING VEGF.
FW553736 - IRNA AGENTS TARGETING VEGF.
HI963442 - Sequence 372 from Patent EP1735009.
HV496681 - JP 2011518117-A/1909: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983064 - JP 2011188866-A/372: IRNA AGENTS TARGETING VEGF.
HZ402198 - JP 2015177801-A/1909: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420295 - JP 2014094020-A/372: IRNA AGENTS TARGETING VEGF.
LZ247466 - JP 2016135144-A/372: IRNA AGENTS TARGETING VEGF.
FW553737 - IRNA AGENTS TARGETING VEGF.
HI963443 - Sequence 373 from Patent EP1735009.
HV496682 - JP 2011518117-A/1910: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV497030 - JP 2011518117-A/2258: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983065 - JP 2011188866-A/373: IRNA AGENTS TARGETING VEGF.
HZ402199 - JP 2015177801-A/1910: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ402547 - JP 2015177801-A/2258: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420296 - JP 2014094020-A/373: IRNA AGENTS TARGETING VEGF.
LZ247467 - JP 2016135144-A/373: IRNA AGENTS TARGETING VEGF.
FW553751 - IRNA AGENTS TARGETING VEGF.
HI963457 - Sequence 387 from Patent EP1735009.
HV496696 - JP 2011518117-A/1924: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983079 - JP 2011188866-A/387: IRNA AGENTS TARGETING VEGF.
HZ402213 - JP 2015177801-A/1924: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420310 - JP 2014094020-A/387: IRNA AGENTS TARGETING VEGF.
LZ247481 - JP 2016135144-A/387: IRNA AGENTS TARGETING VEGF.
FW553752 - IRNA AGENTS TARGETING VEGF.
HI963458 - Sequence 388 from Patent EP1735009.
HV496697 - JP 2011518117-A/1925: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983080 - JP 2011188866-A/388: IRNA AGENTS TARGETING VEGF.
HZ402214 - JP 2015177801-A/1925: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420311 - JP 2014094020-A/388: IRNA AGENTS TARGETING VEGF.
LZ247482 - JP 2016135144-A/388: IRNA AGENTS TARGETING VEGF.
FW553753 - IRNA AGENTS TARGETING VEGF.
HI963459 - Sequence 389 from Patent EP1735009.
HV496698 - JP 2011518117-A/1926: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983081 - JP 2011188866-A/389: IRNA AGENTS TARGETING VEGF.
HZ402215 - JP 2015177801-A/1926: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420312 - JP 2014094020-A/389: IRNA AGENTS TARGETING VEGF.
LZ247483 - JP 2016135144-A/389: IRNA AGENTS TARGETING VEGF.
FW553754 - IRNA AGENTS TARGETING VEGF.
HI963460 - Sequence 390 from Patent EP1735009.
HV496699 - JP 2011518117-A/1927: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983082 - JP 2011188866-A/390: IRNA AGENTS TARGETING VEGF.
HZ402216 - JP 2015177801-A/1927: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420313 - JP 2014094020-A/390: IRNA AGENTS TARGETING VEGF.
LZ247484 - JP 2016135144-A/390: IRNA AGENTS TARGETING VEGF.
FW553755 - IRNA AGENTS TARGETING VEGF.
HI963461 - Sequence 391 from Patent EP1735009.
HV496700 - JP 2011518117-A/1928: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983083 - JP 2011188866-A/391: IRNA AGENTS TARGETING VEGF.
HZ402217 - JP 2015177801-A/1928: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420314 - JP 2014094020-A/391: IRNA AGENTS TARGETING VEGF.
LZ247485 - JP 2016135144-A/391: IRNA AGENTS TARGETING VEGF.
FW553756 - IRNA AGENTS TARGETING VEGF.
HI963462 - Sequence 392 from Patent EP1735009.
HV496701 - JP 2011518117-A/1929: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983084 - JP 2011188866-A/392: IRNA AGENTS TARGETING VEGF.
HZ402218 - JP 2015177801-A/1929: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420315 - JP 2014094020-A/392: IRNA AGENTS TARGETING VEGF.
LZ247486 - JP 2016135144-A/392: IRNA AGENTS TARGETING VEGF.
FW553757 - IRNA AGENTS TARGETING VEGF.
HI963463 - Sequence 393 from Patent EP1735009.
HV496702 - JP 2011518117-A/1930: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983085 - JP 2011188866-A/393: IRNA AGENTS TARGETING VEGF.
HZ402219 - JP 2015177801-A/1930: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420316 - JP 2014094020-A/393: IRNA AGENTS TARGETING VEGF.
LZ247487 - JP 2016135144-A/393: IRNA AGENTS TARGETING VEGF.
FW553758 - IRNA AGENTS TARGETING VEGF.
HI963464 - Sequence 394 from Patent EP1735009.
HV496703 - JP 2011518117-A/1931: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983086 - JP 2011188866-A/394: IRNA AGENTS TARGETING VEGF.
HZ402220 - JP 2015177801-A/1931: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420317 - JP 2014094020-A/394: IRNA AGENTS TARGETING VEGF.
LZ247488 - JP 2016135144-A/394: IRNA AGENTS TARGETING VEGF.
FW553759 - IRNA AGENTS TARGETING VEGF.
HI963465 - Sequence 395 from Patent EP1735009.
HV496704 - JP 2011518117-A/1932: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983087 - JP 2011188866-A/395: IRNA AGENTS TARGETING VEGF.
HZ402221 - JP 2015177801-A/1932: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420318 - JP 2014094020-A/395: IRNA AGENTS TARGETING VEGF.
LZ247489 - JP 2016135144-A/395: IRNA AGENTS TARGETING VEGF.
FW553760 - IRNA AGENTS TARGETING VEGF.
HI963466 - Sequence 396 from Patent EP1735009.
HV496705 - JP 2011518117-A/1933: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983088 - JP 2011188866-A/396: IRNA AGENTS TARGETING VEGF.
HZ402222 - JP 2015177801-A/1933: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420319 - JP 2014094020-A/396: IRNA AGENTS TARGETING VEGF.
LZ247490 - JP 2016135144-A/396: IRNA AGENTS TARGETING VEGF.
FW553761 - IRNA AGENTS TARGETING VEGF.
HI963467 - Sequence 397 from Patent EP1735009.
HV496706 - JP 2011518117-A/1934: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983089 - JP 2011188866-A/397: IRNA AGENTS TARGETING VEGF.
HZ402223 - JP 2015177801-A/1934: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420320 - JP 2014094020-A/397: IRNA AGENTS TARGETING VEGF.
LZ247491 - JP 2016135144-A/397: IRNA AGENTS TARGETING VEGF.
FW553762 - IRNA AGENTS TARGETING VEGF.
HI963468 - Sequence 398 from Patent EP1735009.
HV496707 - JP 2011518117-A/1935: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983090 - JP 2011188866-A/398: IRNA AGENTS TARGETING VEGF.
HZ402224 - JP 2015177801-A/1935: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420321 - JP 2014094020-A/398: IRNA AGENTS TARGETING VEGF.
LZ247492 - JP 2016135144-A/398: IRNA AGENTS TARGETING VEGF.
FW553763 - IRNA AGENTS TARGETING VEGF.
HI963469 - Sequence 399 from Patent EP1735009.
HV496708 - JP 2011518117-A/1936: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983091 - JP 2011188866-A/399: IRNA AGENTS TARGETING VEGF.
HZ402225 - JP 2015177801-A/1936: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420322 - JP 2014094020-A/399: IRNA AGENTS TARGETING VEGF.
LZ247493 - JP 2016135144-A/399: IRNA AGENTS TARGETING VEGF.
FW553764 - IRNA AGENTS TARGETING VEGF.
HI963470 - Sequence 400 from Patent EP1735009.
HV496709 - JP 2011518117-A/1937: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983092 - JP 2011188866-A/400: IRNA AGENTS TARGETING VEGF.
HZ402226 - JP 2015177801-A/1937: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420323 - JP 2014094020-A/400: IRNA AGENTS TARGETING VEGF.
LZ247494 - JP 2016135144-A/400: IRNA AGENTS TARGETING VEGF.
FW553765 - IRNA AGENTS TARGETING VEGF.
HI963471 - Sequence 401 from Patent EP1735009.
HV496710 - JP 2011518117-A/1938: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HV983093 - JP 2011188866-A/401: IRNA AGENTS TARGETING VEGF.
HZ402227 - JP 2015177801-A/1938: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF EG5 AND VEGF GENES.
HZ420324 - JP 2014094020-A/401: IRNA AGENTS TARGETING VEGF.
LZ247495 - JP 2016135144-A/401: IRNA AGENTS TARGETING VEGF.
AK125666 - Homo sapiens cDNA FLJ43678 fis, clone T1ESE2000116.
AF024710 - Homo sapiens vascular endothelial growth factor (VEGF) mRNA, 3'UTR.
JD026697 - Sequence 7721 from Patent EP1572962.
JD492253 - Sequence 473277 from Patent EP1572962.

-  Biochemical and Signaling Pathways
  KEGG - Kyoto Encyclopedia of Genes and Genomes
hsa04060 - Cytokine-cytokine receptor interaction
hsa04150 - mTOR signaling pathway
hsa04370 - VEGF signaling pathway
hsa04510 - Focal adhesion
hsa05200 - Pathways in cancer
hsa05211 - Renal cell carcinoma
hsa05212 - Pancreatic cancer
hsa05219 - Bladder cancer

BioCarta from NCI Cancer Genome Anatomy Project
h_vegfPathway - VEGF, Hypoxia, and Angiogenesis
h_hifPathway - Hypoxia-Inducible Factor in the Cardiovascular System
h_no1Pathway - Actions of Nitric Oxide in the Heart

Reactome (by CSHL, EBI, and GO)

Protein P15692 (Reactome details) participates in the following event(s):

R-HSA-4420117 VEGFR2 autophosphorylates
R-HSA-4420099 p-6Y-VEGFR2 binds SHB
R-HSA-4420107 p-6Y-VEGFR2 binds SHC-transforming protein 2
R-HSA-4420143 p-6Y-VEGFR2 binds SH2D2A
R-HSA-4420153 p-6Y-VEGFR2 binds PLCG1
R-HSA-5218815 p-6Y-VEGFR2 binds NCK
R-HSA-5218818 Integrin alphaVbeta3 binds p-6Y-VEGFR2
R-HSA-5218852 p-6Y-VEGFR2 binds PI3K
R-HSA-4420202 PLCG1 disassociates from VEGFR2 and translocate to PM
R-HSA-4420121 SFKs phosphorylate PLCG1
R-HSA-4420140 SRC1-1 binds SH2D2A and is recruited to VEGFR2
R-HSA-4420083 PTK2 binds p-S-SHB and is recruited to p-6Y-VEGFR2
R-HSA-4420128 SRC-1 phosphorylates SHB
R-HSA-5218836 PTK2beta binds alphaVbeta3
R-HSA-5218824 p-6Y-VEGFR2 binds FYN
R-HSA-4420206 Phosphorylation of SRC-1
R-HSA-5357432 AXL binds SRC-1
R-HSA-5218642 PTK2 autophosphorylates
R-HSA-5218645 SRC-1 binds p-Y397-PTK2
R-HSA-5218830 SRC-1 phosphorylates PTK2-beta
R-HSA-5218847 PAK2 binds NCK
R-HSA-5218854 p-Y420-FYN is phosphorylated on S21
R-HSA-5218806 FYN autophosphorylates
R-HSA-5357429 AXL autophosphorylates on Y772 and Y814
R-HSA-5357479 p-AXL binds PI3K
R-HSA-5218643 HSP90AA1 binds p-6Y-VEGFR2
R-HSA-5218640 SRC-1 phosphorylates p-Y397-PTK2
R-HSA-5218838 PXN binds p-6Y,S732-PTK2
R-HSA-5218855 BCAR1 binds p-7Y-PTK2
R-HSA-5218851 p-Y402-PTK2B phosphorylates p-5Y,S732-PTK2 on Y407
R-HSA-5218826 Active ROCK1,ROCK2 phosphorylates p-5Y-PTK2 on S732
R-HSA-5218819 VEGFA dimer:p-6Y-VEGFR2 dimer:PI3K phosphorylates PIP2 to PIP3
R-HSA-5218832 CDC42:GTP binds PAK2
R-HSA-5218814 PAK2 autophorylates
R-HSA-5218812 FYN phosphorylates PAK2
R-HSA-5218820 Src kinases phosphorylate VAV
R-HSA-5218809 PTK2 and SRC-1 phosphorylate PXN on Y31 and Y118
R-HSA-5218828 PTK2/SRC-1 phosphorylates BCAR1
R-HSA-5218822 CRK binds BCAR1 and or PXN
R-HSA-5218811 DOCK180:ELMO binds CRK
R-HSA-5218839 DOCK180:ELMO exchanges GTP for GDP, activating RAC1
R-HSA-4420097 VEGFA-VEGFR2 Pathway
R-HSA-5218921 VEGFR2 mediated cell proliferation
R-HSA-194138 Signaling by VEGF
R-HSA-9006934 Signaling by Receptor Tyrosine Kinases
R-HSA-162582 Signal Transduction
R-HSA-195378 Homodimerization of VEGF proteins
R-HSA-194311 VEGFA,B,PLGF bind to VEGFR1 leading to receptor dimerization
R-HSA-194310 VEGF-A,C,D bind to VEGFR2 leading to receptor dimerization
R-HSA-481007 Exocytosis of platelet alpha granule contents
R-HSA-1234158 Regulation of gene expression by Hypoxia-inducible Factor
R-HSA-8866910 TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
R-HSA-194313 VEGF ligand-receptor interactions
R-HSA-6785807 Interleukin-4 and 13 signaling
R-HSA-1234174 Regulation of Hypoxia-inducible Factor (HIF) by oxygen
R-HSA-8864260 Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors
R-HSA-195399 VEGF binds to VEGFR leading to receptor dimerization
R-HSA-114608 Platelet degranulation
R-HSA-194138 Signaling by VEGF
R-HSA-449147 Signaling by Interleukins
R-HSA-2262749 Cellular response to hypoxia
R-HSA-212436 Generic Transcription Pathway
R-HSA-76005 Response to elevated platelet cytosolic Ca2+
R-HSA-9006934 Signaling by Receptor Tyrosine Kinases
R-HSA-1280215 Cytokine Signaling in Immune system
R-HSA-2262752 Cellular responses to stress
R-HSA-73857 RNA Polymerase II Transcription
R-HSA-76002 Platelet activation, signaling and aggregation
R-HSA-162582 Signal Transduction
R-HSA-168256 Immune System
R-HSA-8953897 Cellular responses to external stimuli
R-HSA-74160 Gene expression (Transcription)
R-HSA-109582 Hemostasis

-  Other Names for This Gene
  Alternate Gene Symbols: B5BU86, NM_001171623, NP_001165094, O60720, O75875, P15692, Q074Z4, Q16889, Q5UB46, Q6P0P5, Q96KJ0, Q96L82, Q96NW5, Q9H1W8, Q9H1W9, Q9UH58, Q9UL23, VEGF, VEGFA_HUMAN
UCSC ID: uc003owh.3
RefSeq Accession: NM_001171623
Protein: P15692 (aka VEGFA_HUMAN or VEGA_HUMAN)
CCDS: CCDS4907.2, CCDS34457.1

-  Gene Model Information
 
category: coding nonsense-mediated-decay: no RNA accession: NM_001171623.1
exon count: 8CDS single in 3' UTR: no RNA size: 3677
ORF size: 1239CDS single in intron: no Alignment % ID: 100.00
txCdsPredict score: 1586.00frame shift in genome: no % Coverage: 99.56
has start codon: yes stop codon in genome: no # of Alignments: 1
has end codon: yes retained intron: no # AT/AC introns 0
selenocysteine: no end bleed into intron: 0# strange splices: 0
Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.